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Abstract  
Skeletal muscle protein content of lipolytic inhibitor G(0)/G(1) switch gene-2 protein: 
the effect of endurance training 
 
Patrick C Turnbull         Advisor: 
Brock University, 2014      Dr. Sandra J. Peters 
 
 The first and rate-limiting step of lipolysis is the removal of the first 
fatty acid from a triglyceride molecule; it is catalyzed by adipose triglyceride lipase 
(ATGL). ATGL is co-activated by comparative gene identification-58 (CGI-58) and 
inhibited by the G(0)/G(1) switch gene-2 protein (G0S2). G0S2 has also recently been 
identified as a positive regulator of oxidative phosphorylation within the 
mitochondria. Previous research has demonstrated in cell culture, a dose dependent 
mechanism for inhibition by G0S2 on ATGL. However our data is not consistent with 
this hypothesis. There was no change in G0S2 protein content during an acute 
lipolytic inducing set of contractions in both whole muscle, and isolated mitochondria 
yet both ATGL and G0S2 increase following endurance training, in spite of the fact 
that there should be increased reliance on intramuscular lipolysis. Therefore, 
inhibition of ATGL by G0S2 appears to be regulated through more complicated 
intracellular or post-translation regulation. 
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Skeletal muscle insulin resistance is pivotal in the development of type II diabetes 
(72). The cause(s) of insulin resistance in skeletal muscle are currently unknown, but 
reports have linked higher intramyocellular lipids levels with the development of type II 
diabetes (29). Interestingly, two sub-populations of people have been identified as having 
a significantly increased intramyocellular lipid content, the obese and the endurance 
trained, colloquially known as the ‘athletes paradox’ because endurance trained 
individuals efficiently use fat as a fuel and are extremely insulin sensitive. This 
introduces the notion that intramyocellular content alone does not cause insulin 
resistance, however the dynamics between skeletal muscle anabolic and catabolic lipid 
processes appears to be a crucial physiological system worth further exploration (29). 
A 
 
B 
 
Figure 1. Adapted from Amati et al. (4).NWA: Normal weight active; NWS: Normal 
weight sedentary; OBS: Obese sedentary. Figure A: A cross sectional image of 
skeletal muscle. NWA has an organized large lipid droplet located next to the 
mitochondria, with OBS showing a scattered lipid formation compared to NWS. 
Figure B: Bar graph depicting IMTG content within skeletal muscle. NWA and 
OBS have elevated IMTG content when compared to NWS. 
 
 Improper regulation of lipolysis leads to incomplete breakdown products: fatty-acyl 
coenzyme A, diacylglyerols and ceramides that are thought to be lipotoxic. Therefore the 
lead to an elevated pool of neutral DAGs, similar to that
of triglycerides that can be used as a fuel source during
physical activity. Taken together, these data suggest an
enzymatic proﬁle of enhanc d neutral lipid storage and
oxidation associated with enhanced insulin sensitivity with
exercise training.
These human studies cannot directly determine mech-
anisms or causes of IR. Although we did not determine
whether IMCLs are associated with speciﬁc defects in
insulin signaling, we clearly show that insulin-stimulated
glucose disposal in skeletal muscle differed according to
study groups. Additional studies are needed to examine
whether the speciﬁc lipid species or their cellular location,
in particular DAG within muscle, are mechanistically linked
with impaired insulin signaling. It will also be important to
determine whether the fatty acid composition of the diet
affects insulin action within muscle because dietary patterns
have been shown to inﬂuence lipid metabolite content and
saturation (3). We did not measure other intracellular lipids
that have been implicated in muscle IR, such as long-chain
fatty acyl-CoA (52,53) because of the limited availability of
tissue within the relatively small biopsy samples. Another
important element to consider is that the amount and
intensity of physic l activity perform d by these highly
trained athletes do not allow us to extrapolate these
ﬁndings in athletes to more moderate physical activity as
emphasized for general health. Thus, the possibility remains
that there is some threshold level or dose-response effect of
physical activity on insulin sensitivity and these lipids.
In summary, high-level exercise training was unex-
pectedly associated with considerably higher total DAG
content within skeletal muscle concomitant with higher
insulin sensitivity, thus extending the athletes paradox to
muscle DAGs and to triglycerides across ﬁber types.
Therefore, the total cellular DAG content cannot explain
skeletal muscle IR. This suggests instead a role for speciﬁc
molecular species of DAGs and possibly their subcellular
location in this metabolic abnormality. Ceramides and S1P,
on the other hand, are consistently elevated in obese and
insulin-resistant muscle. Moreover, formation and metabolism
FIG. 4. Mitochondria and markers of oxidative capacity in vastus lateralis. Mitochondria volume density (A), example of micrographs (B), and SDH
content (C). Bars are mean values, and error bars are SEMs. The letters A, B, and C above the bars denote signiﬁcant differences between groups
(P < 0.05, one-way ANOVA).
F. AMATI AND ASSOCIATES
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implications of the breakdown of stored lipids is imperative to healthy body functions (1, 
4, 40). Intracellular lipids are stored within dynamic organelles known as lipid droplets. 
Research to date has been involved in the investigation of lipid droplet storage (synthesis) 
and use (lipolysis) within a variety of tissues, most notably adipose tissue. However, little 
work has been completed in skeletal muscle, and very little work has been done on the 
activation and inhibition of the rate-limiting lipase in skeletal muscle, specifically 
towards the potential inhibition of lipolysis.  
 This thesis examines the relationship of the rate-limiting enzyme, adipose 
triglyceride lipase (ATGL), to several protein regulators within a variety of known 
metabolically varying skeletal muscles, and the effects of endurance training on these 
proteins. 
 
  
 4 
Chapter 2 
Literature Review 
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Overview of lipolysis  
Adipose tissue, specifically white adipose tissue, is the main energy storage site in 
mammals (50). Energy storage is defined as the difference between energy consumption 
compared to energy expenditure, and energy, when referring to mammals, comes in the 
form of food. If energy intake is greater than the body’s energy demands, excess energy 
will then be stored in the form of adipose tissue. When non-esterified fatty acids 
(NEFAs) are consumed, or created through fatty acid biosynthesis from excess 
carbohydrates, they are esterified into an inert, non-active form known as triacylglycerol 
(TG) (50). The structure of a TG is three fatty acids bound to a glycerol backbone.  
 
Figure 2. Basic structure of a triglyceride. With the removal of one of the three fatty 
acids, the compound is known as a diglyceride. With the removal of two of the three 
fatty acids, the compound is known as a monoglyceride. 
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In this form, a sequence of catalyzed reactions must ensue to release the fatty acid 
to be metabolized for ATP production. TGs are stored in organelles known as lipid 
droplets, and will remain until they are required to fuel ATP production. High levels of 
NEFAs are toxic to cell viability, and converting NEFAs into neutral TGs protects the 
cell from the cytotoxic effects (52, 79). When energy demands increase beyond energy 
intake, these lipid droplets will be catabolized starting with the hydrolysis of the TG and 
ending in the production of ATP through β-oxidation. This process of fatty acid release 
from TGs is known as lipolysis.  
 
Figure 3. Visual representation of the lipolysis cascade. The removal of the first fatty 
(FA) acid from the triglyceride (TG) molecule is catalyzed by the first, and rate-
limiting enzyme adipose triglyceride lipase. The removal of the second FA is 
catalyzed by hormone sensitive lipase (HSL), with the removal of the final FA being 
catalyzed by monoglyceride lipase (MGL). 
 
Lipolysis begins with the hydrolysis of the first fatty acid, and the production of 
diglyceride (DG) through the activity of adipose triglyceride lipase (ATGL) (98). ATGL 
activity is under dual regulation and is the rate-limiting step in TG breakdown. It is 
activated by interaction with comparative gene identification-58 (CGI-58) (49), and 
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inhibited by the recently discovered G (0)/G (1) switch gene-2 (G0S2) protein (94). The 
complex interaction of ATGL and its two regulators, CGI-58 and G0S2, potentially 
dictate the rate at which lipolysis occurs. Once a DG is produced, hormone sensitive 
lipase (HSL) will catalyze the reaction of converting the DG into monoglyceride (MG) 
with the release of another fatty acid. The final fatty acid is cleaved off by monoglyceride 
lipase (MGL), releasing it from the glycerol backbone. The released fatty acids and 
glycerol from adipose tissue will be transported to, and used by other tissues depending 
on metabolic needs. Adipose tissue TG degradation is stimulated in times of increased 
whole body energy demand such as fasting or during exercise.  
In adipose tissue, lipid droplets are surrounded by PLIN1, a protein only 
expressed in this tissue (53). PLIN1 is, in part, thought to allow for controlled access to 
TGs by degrading lipases (13). ATGL is found both on the lipid droplet and in the 
cytosol of adipocytes. While it is believed that ATGL is responsible for catalyzing basal 
lipolysis during times of low energy demand, it is not until activation by association with 
CGI-58 that ATGL is up regulated to increase fatty acid release (49). In a basal state, 
there is a constant cycling of TGs, with them being hydrolyzed into DGs, and then the 
cleaved fatty acids are re-esterified to reproduce TGs. In the basal state, CGI-58 is bound 
to PLIN1, but when G-mediated protein signaling is activated via adipocyte β-adrenergic 
receptors, intracellular cAMP levels increase, causing protein kinase A (PKA) activation 
(17). PKA then phosphorylates PLIN1 and HSL, causing HSL to translocate to the lipid 
droplet membrane (12). PLIN1 phosphorylation causes both the release of bound CGI-58, 
but also is thought to reconfigure the lipid droplet into smaller droplets allowing 
increased surface area for lipase exposure (13). During this process, cytosolic ATGL is 
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thought to translocate to the surface of the lipid droplet, and with increased interaction 
with the recently released CGI-58 from PLIN1, begins the lipolysis cascade (refer to 
Figure 4). Little is known about inhibition of these processes, but it is thought that G0S2 
will inhibit not only ATGL activity, but also override any activation due to bound CGI-
58, suggesting non-competing pathways for altering ATGL behavior (55). It is believed 
that ATGL is bound to G0S2 at all times; therefore further modification of either G0S2 or 
ATGL or both must ensue for a change in activation (94). 
 
A. Basal 
 
B. Stimulated 
 
Figure 4. A. Depiction of basal adipose tissue state. B. Lipolysis is started by the co-
activation of ATGL by CGI-58, followed by the phosphorylation of HSL, cause 
HSL to translocate to the lipid droplet, finally, MGL removing the final fatty acid 
leading to the complete hydrolysis of a TG for FA and glycerol release. Adapted 
from Yang et al. (94). 
 
 Lipolysis is not uniformly regulated across all lipid droplets in the body; there are 
several differences between adipose tissue and skeletal muscle lipolysis involving 
regulation of lipolytic pathways, and the actual lipid droplets themselves. Lipid droplets 
exist in many tissues such as liver, steroidogenic tissues and skeletal muscle. Skeletal 
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muscle TG breakdown is responsible for greater than 50% of the total fat breakdown 
during low to moderate intensity muscle contraction and exercise, but much less is 
understood about the regulation of muscle lipolysis (23, 60).  
 
Lipolysis in skeletal muscle 
 Skeletal muscle is heavily reliant on fat oxidation for energy both at rest and 
during exercise. The mechanisms regulating lipolysis within skeletal muscle are still 
relatively unknown. However, it is thought that intramuscular TGs (IMTGs) are 
mobilized and consumed through metabolic (intracellular) and hormonal regulation. 
Unlike adipose tissue lipolysis, which is stimulated during times of whole body energy 
depletion, skeletal muscle lipolysis appears to be specific towards the individual energy 
demand of a given muscle, and is up regulated during exercise and down regulated in a 
state of insulin resistance due to a high fat diet (34, 44, 69). Whole body lipolysis is 
present even during periods of low exercise demand (e.g., at 25% VO2max), however 
during increasing exercise intensities, use of plasma FA levels remained the same, yet 
IMTG lipolysis increases at higher intensities (65% VO2max) and appears to be most 
efficient in this range (69). Fatty acids release from adipose tissue are systemically used 
for energy production in many tissues including skeletal muscle, whereas IMTG lipolysis 
is directed towards intracellular mitochondria for skeletal muscle energy production.  
The relationship between ATGL and CGI-58 is better understood, especially in 
adipose tissue, however the interaction that the more recently discovered G0S2 has on 
ATGL (or possible CGI-58) is still relatively unknown. In adipose, CGI-58 is released 
with phosphorylation of PLIN1, which allows for the interaction between CGI-58 and 
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ATGL up regulating the activity of ATGL from a basal to active state, and in doing so, 
significantly increasing the rate of lipolysis (82, 92). Despite the apparent absence of 
PLIN1 in muscle (91), the interaction between CGI-58 and ATGL is still believed to be 
essential for the activation of ATGL to initiate the first cascading step of skeletal muscle 
lipolysis (22).  
 HSL was originally thought to be the only lipase responsible for complete 
hydrolysis of TGs in both adipose tissue and skeletal muscle (8), subsequent work using 
HSL-deficient mouse embryonic fibroblasts, TGs were still being catabolized, suggesting 
another non-HSL TG specific lipase (64). ATGL was only discovered as the rate-limiting 
lipase of TG hydrolysis in 2004 (98), and as such much more is known about the 
modulation of HSL in general and particularly within skeletal muscle. 
 
Structure and Function of the Lipid Droplet 
 Although adipose tissue is the most abundant site of stored lipid droplets, the 
body can store a finite amount of lipid droplet in non-adipose tissue (22). There is only 
one lipid droplet existing within most adipocytes. The size of the lipid droplet can be ten 
times larger than lipid droplets found in non-adipocyte’s at ectopic sites such as liver and 
skeletal muscle (83). While this may be the most prominent difference between adipocyte 
lipid droplets and non-adipocyte lipid droplets, many other differences do exist. In 
skeletal muscle, many small lipid droplets exist, and they are in proximity to both the 
mitochondria and the sarcoplasmic reticulum, mainly occupying the spaces between 
mitochondria in both the subsarcolemmal and myofibrillar regions (77). During times of 
increased energy turnover within skeletal muscle (i.e., exercise), it is believed that the 
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proximity of the lipid droplet to the mitochondria plays a functional role in accelerating 
fatty acid oxidation (84). The structures of most lipid droplets are very similar despite 
size differences. The basic structure of the lipid droplet comprises of a phospholipid 
monolayer surface with over 300 identified proteins embedded into the surface layer, and 
an esterified lipid core composed of TGs and cholesterol esters (62, 83). Lipid droplets 
are physiologically unique in that they are the only organelle without a phospholipid 
bilayer, and are surrounded by only a monolayer. Not much is known about lipid droplets 
as dynamic intracellular organelles, since they were originally thought to solely be inert 
lipid storage sites. It is postulated that the endoplasmic reticulum is the site of lipid 
droplet synthesis (11). 
 
Adipose Triglyceride Lipase 
The first fatty acid of the TG was originally thought to be cleaved off solely by 
HSL which has both TG and DG lipase activity (8). It was hypothesized that changes in 
the phosphorylation state of HSL by cAMP-mediated PKA activity dictated its catalytic 
behavior, and through this, altered the rates of lipolysis (8). While it has been proven that 
HSL can indeed cleave off a FA from a TG, it has a ten-fold greater affinity for DGs over 
TGs (25). However, in HSL knockout mice, DG accumulation in adipose tissue 
suggested that another lipase was responsible for the rate-limiting step of lipolysis since 
TGs were being catabolized into DGs even in the absence of HSL, contrary to previous 
belief (32). This was observed across several tissues, demonstrating that whatever this 
preferential lipase towards TGs was, it was not adipose tissue specific, due to DG 
accumulation in skeletal muscle and liver as well as adipose tissue (32). In 2004, 
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Zimmerman et al. identified through gene and protein screening, a protein that matched 
other lipases, yet had the ability to catalyze the reaction of TG to DG while releasing a 
fatty acid. This was further proven with the demonstration that adipose triglyceride lipase 
(ATGL) causes FA release from TGs using ATGL extracts in vitro (42, 87, 98). At the 
time of discovery, two other groups identified desnutrin (87) and calcium-independent 
phospholipase A2ζ (42) that are now known to be identical proteins to ATGL. The role of 
ATGL is best understood in adipose tissue, but it is currently not as well understood in 
skeletal muscle. In an ATGL knockdown mouse model, there was a significant decrease 
in TG catabolism and lipolytic activity causing a shift to glucose metabolism (31). 
Subsequently, in the ATGL-knockout mouse, TG accumulation in cardiac tissue caused 
premature death due to cardiomyopathy (31). Schoiswohl et al. (74) developed an ATGL-
knockout mouse without the ability to produce ATGL in all tissues except the heart 
(cardiac muscle specific ATGL-knockout). The cardiac muscle specific ATGL-knockout 
mouse had a normal life span, but was unable to increase FA levels during exercise 
leading to a rapid depletion of liver glycogen, suggesting ATGL as a crucial regulator of 
energy control in skeletal muscle during times of heightened energy demand (74). ATGL 
also has the capability for transacylase activity, although the purpose of this function of 
this is currently unknown (42) 
ATGL, unlike HSL, has a strong substrate affinity towards TGs, with very low 
catabolic ability towards DGs (98). Like HSL, ATGL expression appears to be 
predominantly in oxidative type I muscle fibers (43). To date, we have an incomplete 
understanding of the regulation of ATGL, particularly in skeletal muscle. Regulation of 
this lipase appears to be crucial in the rates of lipolysis across all tissues.  
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Hormone Sensitive Lipase (HSL) 
 Not only was it thought that HSL was the lipase responsible for both the initial 
step in lipolysis, the breakdown of TGs into DGs, but also the subsequent step of 
hydrolyzing DGs into MGs (25). The original belief was that HSL was the sole lipase 
responsible for the catalyzing the breakdown of TGs into FAs for specific metabolic 
fates. In vitro experiments also demonstrate that HSL can hydrolyze MGs, but to a much 
lesser extent (25). A non-obese mouse HSL knock-out was produced and demonstrated 
an accumulation of DGs within their adipose tissue, it lead to the the realization that 
another enzyme responsible for the first reaction must exist, but also indicated that the 
primary role of HSL is most likely to catalyze DGs into MGs (32, 64, 88, 97).  HSL is 
most abundantly expressed in white and brown adipose tissue, but also expressed in other 
tissues such as smooth, cardiac and skeletal muscle (35, 46). HSL activity is regulated 
through phosphorylation by both protein kinase A (PKA) and adenosine monophsohphate 
(AMP) – activated protein kinase (AMPK) (5, 27). During basal state, HSL is 
phosphorylated at serine (Ser-)565 by AMPK to block phosphorylation by PKA 
converting HSL into an antilipolytic state (27, 28). In vitro experimentation of rat 
adipocytes led to the understanding that HSL has several phosphorylation sites and is 
involved in complex regulation with potentially Ser-659 and Ser-660 being the two most 
important sites for HSL up-regulation by PKA activation (5). PKA phosphorylation of 
HSL via β-adrenergic stimulation accounts for a 2-fold increase in HSL activity, yet β-
adrenergic activation of PKA causes a 100-fold increase of TG hydrolysis (96). The 
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regulation of HSL is important in the process of lipolysis, however it is no longer thought 
to be the sole lipase responsible for the breakdown of TGs. 
 
Monoglyceride Lipase (MGL) 
MGL is currently recognized as the enzyme responsible for MG hydrolysis, 
catalyzing the reaction of the removal of the final fatty acid from the glycerol backbone 
and releasing both the fatty acid and the glycerol for their respective roles in metabolic 
processes. Activity of MGL is roughly ten-fold higher than that of ATGL, suggesting that 
MGL is not rate limiting in terms of overall lipolytic rates and its activity is substrate 
driven (18). To study this further, Taschler et al. (85) developed an MGL knockout 
mouse. The MGL knockout mice had a significant decrease in MG hydrolase activity, 
and an increase of MG across a variety of tissues, indicating that it is important for this 
final step. 
 
Comparative Gene Identification-58 (CGI-58) 
 In the search for novel human genes, Caenorhabditis elegans was used as a 
scaffold for comparative identification of human genes. The complete genome 
composition was determined for Caenorhabditis elegans, a roundworm, therefore using 
the proteome from this, the first completed genome of a multicellular organism allowed 
proper identification of human like genes. The nomenclature was given as CGI, 
comparative gene identification. Over 150 full-length human genes were identified (47). 
Several mutations were identified in one of the CGI genes as being related to Chanarin-
Dorfman Syndrome, a syndrome related to the manifestation of high concentrations of 
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intracellular TGs across many tissues (15). Eight mutations were discovered in the CGI-
58 gene region in patients with Chanarin-Dorfman Syndrome (51). While it was noted 
that CGI-58 was not a lipase, it was discovered that CGI-58 had an activating effect on 
lipolysis, as it was established that it positively regulates ATGL hydrolysis by an increase 
of greater than 20-fold (49). 
 
CGI-58 up regulates ATGL activity 
 ATGL is active under basal conditions, however, when activated by CGI-58, TG 
hydrolysis is increased 20-fold (49). In the absence of ATGL, CGI-58 cannot increase 
lipolytic activity via any other route; therefore it is dependent on ATGL to influence 
lipolytic activity (75). To increase ATGL activity, a physical interaction must exist 
between ATGL and CGI-58, although details on this interaction are not well understood. 
In cultured adipocytes from CGI-58 knockout mice, Osumi and colleagues (93) were able 
to demonstrate that, in both basal and PKA stimulated lipolysis, TG hydrolysis rates did 
not change in the absence of the co-activator, demonstrating the importance of CGI-58 on 
lipolytic rates. In 3T3-L1 adipoctyes, CGI-58 knockdown induced a 20% decrease in 
lipolysis in the basal condition; suggesting a role for CGI-58 even in a basal state.  
In adipose tissue, it is believed that PLIN1 releases CGI-58 into the cytosol to 
increase the activity of ATGL through a physical interaction (82, 92). Although PLIN1 is 
absent in skeletal muscle (91), the interaction between CGI-58 and ATGL still appears to 
be important in controlling lipolytic rates (22). During muscle contraction, ATGL activity 
is significantly increased by interaction with CGI-58, demonstrating that another 
mechanism for lipid turnover exists outside of adipose tissue (58). While the regulation of 
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ATGL is currently not well understood in skeletal muscle, the interaction between ATGL 
and CGI-58 appears to be pivitol in the activation of lipolysis. In skeletal muscle lysates, 
the progressive addition of CGI-58 led to a dose dependant increase of TG hydrolysis 
(74). Alternatively, in ATGL deficient adipose tissue in culture, the introduction of CGI-
58 alone was unable to induce lipolysis, suggesting that CGI-58 only upregulates ATGL 
as a target for modulating lipolysis (75). However, the specific mechanism by which 
CGI-58 interacts with ATGL is still unknown. In HeLa cells co-expressed with ATGL 
and CGI-58, it appears that CGI-58 is always located around the lipid droplet, whereas 
ATGL is found both on and off the lipid droplet, it is believed that ATGL translocates to 
the lipid droplet anchored by its’ hydrophobic domain (55). Removal of the hydrophobic 
domain of ATGL prevented ATGL from anchoring to the lipid droplet, causing excess 
ATGL in the cytosol, however, with CGI-58 co-expression ATGL was able to move 
towards the lipid droplet starting lipolysis. 
 
G(0)/G(1) Switch Gene-2 protein 
 The G0/G1 switch genes (G0S) were identified using cDNA libraries to examine 
oncogenes that may have an impact in lymphotropic viruses and are involved in inducing 
cells to go from the G0 to the G1 phase in the cell cycle (80).  In cultured blood 
mononuclear cells, the G0/G1 switch gene-2 (G0S2) protein was discovered during the 
G0 to G1 phase of a drug-induced cell cycle (71). G0S2 is derived from a 103 amino acid 
sequence with the gene found on chromosome 1 (71, 80). Protein structure analyses have 
led to the discovery of two potential phosphorylation sites from protein kinase C and 
casein kinase II (71). However, no evidence yet exists as to whether G0S2 can be 
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phosphorylated under physiological conditions. Implications have been made about 
functions of G0S2, it is involved in cell proliferation (80), apoptosis, inflammation, 
carcinogenesis, but the most prominent function appears to be in down regulation of 
ATGL activity (55, 94). G0S2 expression is much higher in brown and white adipose 
tissue, but is still found in other metabolically active tissues such as the liver, heart and 
skeletal muscle (2, 95).  
In G0S2 overexpressing HeLa cells, G0S2 localizes to the lipid droplet membrane 
and prevents TG hydrolysis (94). Whereas in a G0S2 knockdown HeLa cell, basal and 
stimulated lipolysis were both significantly increased (94). Taken together this adds 
further evidence that the mechanisms involved in actual the interaction between G0S2 
and ATGL still remain unknown, however it appears that G0S2 and ATGL are bound 
regardless of ATGL activity and even in the presence of CGI-58 (55). In a G0S2 
overexpressing cell line, activation of ATGL through CGI-58 was unable to increase lipid 
droplet degradation, suggesting non-competing pathways for lipid droplet control (55). It 
is suggested that the potential inhibition of ATGL by G0S2 is done through G0S2 
blocking substrate availability to ATGL, and that G0S2 and CGI-58 act on ATGL 
through separate non-competing mechanisms since regardless of CGI-58 presence and 
interaction with ATGL, G0S2 will dose dependently inhibit ATGL function (55). 
 Not only is G0S2 important in the down-regulation of ATGL, it also may play a 
functional role in adipogenesis as well. Lee et al. (2) examined both the fat cell fraction 
and the stromal vascular fraction of adipose tissue. The fat cell fraction contains 
adipocytes, while the stromal vascular fraction contains mostly undifferentiated pre-
adipocytes. The expression of G0S2 was over 16-fold higher expression in the fat cell 
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fraction compared to the stromal vascular fraction, suggesting a possible role in 
adipogenesis and lipid accumulation during adipocyte development. During 3T3-L1 
adipogenesis, G0S2 increased significantly during the adipogenesis cycle (95). This is 
consistent with G0S2 being up regulated by the transcription factor: peroxisome 
proliferator activated receptor γ (PPARγ) (95). PPARγ is highly expressed in adipose 
tissue, but is also present in skeletal muscle, and is viewed as an overall regulator of 
adipogenesis (6, 68, 70, 86, 95). The G0S2 gene also contains a carbohydrate response 
element resulting in direct sensitivity to altered glucose concentrations (56). Parikh et al. 
(65) in skeletal muscle following a hyperinsulinemic euglycemic clamp (in vivo) 
discovered that G0S2 mRNA expression rose significantly demonstrating the acute 
responsiveness to elevated insulin concentrations and increased muscle glucose uptake. 
In human adipose tissue following fasting conditions, an increase in ATGL mRNA and 
protein expression was observed, yet a decrease in G0S2 mRNA and protein expression 
is observed (63). This is understandable since in a fasting state, there is a heightened need 
for fat mobilization through increased lipase activity and a decreased need for inhibition 
of lipolysis. This is also consistent with the potential inhibiting mechanism of G0S2 
being dose dependently regulated, since a decrease in G0S2 would facilitate ATGL 
catalytic ability. However, these data challenge the notion that G0S2 and ATGL are 
coordinately regulated, and obviously not bound to a one-to-one stoichiometry in adipose 
tissue.  Therefore, further exploration into the contribution of G0S2 inhibition to the 
regulation of lipolysis is warranted. Endurance training caused increases in ATGL protein 
content, with no changes in CGI-58 and no changes in total G0S2 protein content in 
vastus lateralis muscle biopsies from obese adult men (54). However, this does 
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corroborate the idea that G0S2 is a dose dependent modulator since relative to ATGL 
content, G0S2 protein did decrease. 
 Recently, two separate studies have identified G0S2 as a specific mitochondrial 
protein, albeit for almost contradictory purposes. Kioka et al. (45) recently identified 
G0S2 as a positive regulator of oxidative phosphorylation via up regulation of complex V 
(F0F1 ATPase).  On the other hand, Welch et al. (90) identified G0S2 as a pro-apoptotic 
protein, interacting with Bcl-2 to prevent the anti-apoptotic heterodimer formation with 
Bcl-2/Bax. When exposed to cold temperatures, G0S2 knockout mice were better adapted 
to the temperature changes by up regulating known thermogenic genes, potentially 
indicating another mitochondrial role for heat production (57). Given this evidence that 
G0S2 is possibly not only a dose dependent inhibitor of ATGL, but a pro-apoptotic 
protein and a positive regulator of oxidative phosphorylation; more research is needed to 
ascertain a true function of G0S2 for energy regulation. 
 
Skeletal muscle fiber type and the effects of endurance training on IMTG 
metabolism 
 Skeletal muscle fiber types can be separated into three general classifications 
based on several techniques such as histochemical analysis, mitochondrial enzyme 
content and ATPase activity (7, 14, 19, 66). In broad terms, skeletal muscle fiber types 
can be divided into type I, or slow twitch fibers, and type II, or fast twitch fibers. 
Recently, seven skeletal muscle fiber types have been recognized, but for the purpose of 
this review only three general classifications will be examined type I, type IIa and type 
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IIb/x, since these are three broad classifications that can relate to rat skeletal muscle 
tissue.  
 
Fiber type classification 
mATPase Myosin heavy chain biochemical 
I MHCI SO 
IC   
IIC   
IIAC   
IIA MHCIIa FOG 
IIAB   
IIB MCHIIx/d(IIb) FG 
Table 1: Table of fiber type classifications with specifics on type I, IIA and IIB 
 fibers. Adapted from Scott et al. (76) 
 
Type I fibers have slower contractile properties (i.e., time to peak tension, t1/2 relaxation 
time), yet longer time to fatigue.   They rely more heavily on fat oxidation for fuel, which 
contributes to their greater fatigue resistance. Type IIb/x have the fastest contractile 
properties, yet fatigue relatively quickly when compared to type I and IIa, relying more 
on anaerobic and glycolytic energy pathways.  Intermediate type IIa fibers generally are 
in between the contractile properties compared to type I and IIb/x, but have high 
oxidative capacity and high glycolytic capacity as well (reviewed in (76)). Both type I 
and type II fibers store IMTGs, although type I has a greater IMTG content.  Both fiber 
populations demonstrate decreased IMTG content (i.e., IMTG utilization) following an 
acute bout of endurance exercise (78). The rat model allows us to select muscles that are 
predominantly fiber type specific, unlike human skeletal muscle where even more 
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oxidative tissues are mostly mixed fibers. The rat soleus muscle is predominantly a 
postural muscle and contains a high percentage of type I fibers (84% type I; 7% type IIa 
and 9% type IIb/x) (19).  The gastrocnemius muscle can be excised from both the medial 
and lateral portions, yielding both a ‘red’ and a ‘white’ sample.  The red gastrocnemius is 
considered largely type IIa (51% type I; 35% type IIa and 14% type IIb/x) and is highly 
oxidative and glycolytic, and the white gastrocnemius is highly specialized fast-twitch 
glycolytic fibers (0% type I; 0% type IIa and 100% type IIb/x) (19).   
 Following a single exhaustive swimming bout, a decrease in IMTG content was 
noted amongst a variety of rat skeletal muscles. Specifically, a reduction of 48% of 
IMTG in type I soleus, a reduction of 29% in red gastrocnemius (predominantly type IIa), 
with no noticeable difference in IMTG content in the type IIb white gastrocnemius, 
demonstrating preferential depletion of IMTG within oxidative skeletal muscle fiber 
types (81). In skeletal muscle from obese rats following a hyperinsulinemic-euglycemic 
clamp, a reciprocal response was observed between the soleus when compared to mixed 
gastrocnemius, in that there was an increase in IMTG turnover by over 3-fold within the 
soleus, yet decreased IMTG turnover in the gastrocnemius. Prior to the clamp the 
gastrocnemius had a higher IMTG fractional turnover rate compared to the soleus, yet 
following the clamp it was reversed (30). This demonstrates that alterations in IMTG 
turnover are not the same in all fiber types, and that the study of a variety of skeletal 
muscle types is warranted.  
Following prolonged endurance training, the fiber types are altered with noted 
increases in type IIa fibers and decreases of type IIb/x fibers, with little or no change in 
oxidative capacity of the type I fibers (16, 41, 59). However, there is a greater increase in 
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mitochondrial content within type II fibers such that after chronic endurance training 
there is little to no difference in mitochondrial content between type I and type II, 
indicating a shift in fiber type largely through increased mitochondrial biogenesis (16, 41, 
59). They also discovered, however, no increase in β-adrenergic receptor density (59). 
This is important to note since β-adrenergic receptor activation by catecholamines 
promotes lipolysis in a variety of tissues, and it has been shown that mutations in a 
variety of β-adrenergic receptor codons can cause obesity (albeit in adipose tissue) (48). 
Similarly, beneficial mutations in β-adrenergic receptor codons have been known to 
cause an increase in aerobic capacity (73). With a decrease in catecholamine stimulation, 
and no increase in β-adrenergic receptor density, increased reliance on IMTG lipolysis 
must be regulated by other, currently unknown pathways (37). 
 
IMTG dynamics and endurance training 
In skeletal muscle from sedentary mammals, IMTG pools only account for 
roughly 1% of whole body lipid storage. However, during endurance exercise, skeletal 
muscle lipolysis accounts for greater than 50% of fat oxidation with the remainder 
presumably from oxidation of plasma free fatty acids (60). Whole body reliance on 
plasma free fatty acids increases, and a significant reduction in rates of glycogen 
utilization are observed both during and after endurance training. A central adaptation to 
endurance training in terms of skeletal muscle is that there is an increase in carbohydrate 
sparing, with an increase in reliance upon fat oxidation for fuel provision (24, 33, 34). 
Low-to-moderate chronic exercise is a powerful inducer of mitochondrial biogenesis of 
between 50-100% increase within 6 weeks (reviewed by (36)). There is also an increase 
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in lipid droplet-to-mitochondria association following endurance training (4, 20). 
Training results not only in an increase in IMTG utilization, but significant muscle 
glycogen sparing as well. Hurley et al. (39) observed that following 12 weeks of 
moderate intensity endurance training in humans, there was a significant decrease in 
respiratory exchange ratio, but also in a single bout of exercise 48 hours after the training 
protocol there was a decrease in plasma free fatty acids and glycerol, indicating an 
increased reliance on endogenous (or intramuscular) fat stores to sustain energy demands 
during exercise. There was also a 41% increase in muscle glycogen sparing, further 
indicating IMTG content as being relied upon as energy stores, which was corroborated 
further by increased storage at rest and a greater decrease in IMTG content during the 
single bout of exercise following endurance training compared to before. Changes in 
intramuscular shifts towards fat oxidation can be observed as quickly as 31 days, as noted 
by Phillips et al. (67), who noticed increased IMTG depletion following exercise as 
quickly as 5 days into a chronic training regime, with more substantial changes at 31 
days. 
Controversy exists throughout the literature concerning the utilization of IMTG 
before and after endurance training due to the variability in measurements of IMTG 
content (reviewed by (89)). However, there is some evidence that there is a greater 
reliance on IMTG for energy production following endurance training.  In elite endurance 
trained cross-country skiers following a roughly 420 minute race there was a decrease in 
IMTG content by 36.4 mmol/kg dry mass compared to pre race suggesting that IMTGs 
are an important fuel during strenuous prolonged exercise in elite endurance athletes (10, 
26). In a longitudinal study, there was significant increase in IMTG utilization during a 
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single bout of moderate intensity exercise in subjects who participated in twelve weeks of 
endurance training compared to their untrained state (38). 
Endurance training is also known to increase insulin sensitivity.  There has been 
some evidence that this may be related to changes in intramuscular DG and ceramide 
levels, which are potentially lipotoxic, and accumulation has been linked to insulin 
resistance (1, 40). In older obese men and women, muscle DGs and ceramide content 
decreased following 16 weeks of endurance training, with corresponding decreases in 
body weight and fat mass (21). However, in a similar endurance training study with lean 
and obese women, body weight did not change and neither did DG or ceramide content, 
suggesting that adiposity may contribute to lipotoxicity regardless of training status (20).  
With endurance exercise there is also an increase in IMTG synthesis and storage 
suggesting that the dynamic turnover of IMTGs is important in the increase in IMTG 
utilization (9, 61). However, during tetanic stimulation of rat soleus following endurance 
training, Dyck et al. (24) demonstrated that while there was an increase IMTG synthesis 
during contraction (endurance exercised vs. control), IMTG hydrolysis and oxidation 
were reduced in the exercised group by 49% and 30% respectively. This was the first 
study to analyze IMTG turnover in the soleus alone, and the results are surprising given 
that several other studies have indicated increased IMTG utilization following endurance 
training.  However, the soleus is a very unusual muscle given its postural role and high 
type I fiber content, and therefore it would be important to study fiber type differences in 
IMTG utilization adaptations to endurance exercise. 
 In human skeletal muscle following endurance training, ATGL protein content 
increases, which would be consistent with higher rates of IMTG breakdown (3, 4). Alsted 
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et al. (3) discovered that, while ATGL is higher in skeletal muscle in endurance-trained 
men compared to sedentary controls, neither HSL nor CGI-58 content was higher. In 
spite of this, basal lipolysis increased, suggesting that any increase in IMTG hydrolysis is 
mediated by ATGL. Interestingly, even though they observed no change in HSL content, 
there was no increase in DG accumulation - suggesting that HSL activity is not rate 
limiting and must be in excess under both trained and untrained conditions. It would also 
appear that since CGI-58 content remained unchanged, it is potentially saturated in 
skeletal muscle, and that its positive regulatory effects on ATGL are driven solely on the 
changes in concentration/activation of ATGL. Little is known in skeletal muscle 
regarding the regulatory protein G0S2, and no study to date has examined G0S2 
expression following endurance training in healthy tissue. 
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Chapter 3 
 
Statement of the problem  
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In the past ten years, ATGL has been recognized as the rate limiting lipase 
responsible for commencing the cascade of lipolysis in adipose tissue and skeletal 
muscle.  Most studies examined only ATGL protein and mRNA expression with different 
metabolic perturbations, but more recently studies have been including CGI-58 co-
expression as an outcome measure, with most research focusing only in cell models or 
adipose tissue. Very little research to date has focused on co-ordinate expression of 
ATGL, CGI-58 and G0S2 across non-adipose tissues, as well as combining all three 
under one perturbation. Research to date has demonstrated that expression of ATGL and 
G0S2 is not similar in response to fasting in adipose tissue, dispelling the notion that 
ATGL and G0S2 are always co-expressed, further adding evidence to the potential 
mechanism of G0S2 inhibition on ATGL in a dose-dependent manner.  
 
Purpose and hypotheses 
The purpose of this thesis is two fold: 1) To determine relative protein content of 
ATGL, CGI-58 and G0S2 across three metabolically diverse skeletal muscles in order to 
give insight into the relationship between ATGL, CGI-58 and G0S2 and perhaps the 
dose-dependent inhibition of G0S2 on ATGL. 2) To determine the effects of endurance 
training on ATGL, CGI-58 and G0S2 across a variety of skeletal muscles to determine 
fiber type differences, if any, on protein content, as well as to determine if during an 
acute lipolytic inducing contraction whether changes in G0S2 mirror that of IMTG 
breakdown.  
We hypothesize that the soleus will have the greatest ATGL protein content 
compared to the red and white gastrocnemius, with the inverse for G0S2 protein content 
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across the same tissues, with the soleus having the least amount of inhibitor G0S2 
relative to ATGL protein and the highly glycolytic white gastrocnemius having the 
highest amount of G0S2 relative to ATGL. Following endurance training, we expected to 
see increases in ATGL in all three of our skeletal muscles, with no changes in CGI-58, 
and decreased inhibitory G0S2 with the greatest decreases in the oxidative soleus muscle.  
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ABSTRACT 
The rate-limiting enzyme in lipolysis, ATGL, is co-activated by comparative gene 
identification-58 (CGI-58) and inhibited by the G(0)/G(1) switch gene-2 (G0S2) protein. 
There is little work examining G0S2 expression in lipolytic tissues, and the relative 
expression across tissues or in skeletal muscle has not yet been described. Three muscles, 
soleus (SOL), red gastrocnemius (RG), and white gastrocnemius (WG), as well as heart 
were excised from 57-day old male Sprague-Dawley rats (n = 9). QRT-PCR was used for 
mRNA analysis, and western blotting was conducted to determine protein content. ATGL 
and G0S2 protein content were both greatest in the lipolytic SOL, with the least amount 
of both protein content found in the WG. CGI-58 protein content however did not mirror 
ATGL and G0S2 protein content, since the RG had the greatest protein content when 
compared to the SOL and WG. 
When comparing our tissues based on CGI-58-to-ATGL ratio and G0S2-to-
ATGL ratio, it was discovered that contrary to oxidative demand, the glycolytic WG had 
the greatest co-activator CGI-58-to-ATGL ratio with the oxidative SOL having the least, 
and no differences in G0S2-to-ATGL across the three muscle types. These data suggest 
that the content of G0S2 relative to the lipase in skeletal muscle would not predict 
lipolytic potential.   
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INTRODUCTION 
Adipose triglyceride lipase (ATGL) has been described as the rate-limiting 
enzyme of lipolysis (25). ATGL is responsible for catalyzing the removal of the first fatty 
acid from the glycerol backbone of triglycerides (TG), releasing fatty acids for energy 
production and subsequently producing diglycerides (25). It has recently been 
demonstrated that ATGL has dual regulation, where it is activated by comparative gene 
identification-58 (CGI-58) and inhibited by the G(0)/G(1) switch gene-2 protein (G0S2) 
(10, 14, 23). Most studies to date have been conducted in cell culture or in adipose tissue, 
but relatively little is known about the relationship of these three proteins in other 
metabolically active tissues, such as skeletal muscle. 
It appears that ATGL activity is directly influenced by both CGI-58 and G0S2 
since the presence or abundance of these proteins has been demonstrated to alter the 
hydrolyzing rate of ATGL (10, 14, 19), with either activation or inhibition, respectively. 
Yet nothing is known of the ATGL-to-G0S2 or ATGL-to-CGI-58 content ratio amongst 
non-adipose lipolytic tissues such as skeletal muscle and heart. In G0S2 overexpressing 
HeLa cells, G0S2 localizes to the lipid droplet membrane and prevents TG hydrolysis 
(23). In the same HeLa cell model the loss of G0S2 by knockdown expression caused 
both basal and stimulated lipolysis to be significantly increased (23). This would suggest 
that at least in cultured HeLa cells, the content of G0S2 could affect the rate of lipolysis.  
In skeletal muscle, Parikh et al. (17), demonstrated that G0S2 mRNA expression rose 
significantly following a hyperinsulinemic euglycemic clamp (in vivo), demonstrating the 
acute responsiveness of the G0S2 gene to elevated insulin concentrations and increased 
muscle glucose uptake. This would indicate that G0S2 protein content might be expected 
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to decrease lipolysis in response to insulin, although protein content was not measured in 
this study. Taken together, these data would suggest that the relative content of G0S2 to 
the ATGL lipase could play an important role in regulating lipolysis.  Although the 
mechanisms behind the regulation of ATGL by G0S2 are unknown, it appears that G0S2 
and ATGL are bound together regardless of ATGL activity and lipolysis can be down-
regulated even in the presence of CGI-58 (14). In human adipose tissue following fasting, 
an increase in adipose ATGL mRNA and protein expression was observed, yet a decrease 
in G0S2 mRNA and protein expression was also observed (15). This is understandable 
since in a fasting state, there is a heightened need for fat mobilization through increased 
adipose ATGL lipase activity and a decreased need for inhibition of lipolysis. These data 
suggest that expression of the lipase and G0S2 may play a role in regulating lipolytic 
rates, at least in adipose tissue. This inverse response in protein content also challenges 
the notion that G0S2 and ATGL are coordinately regulated, and obviously not bound to a 
one-to-one stoichiometry in adipose tissue. However, little is known about G0S2 in other 
tissues (e.g., skeletal and cardiac muscle) and therefore, further exploration into the 
contribution of G0S2 inhibition to the regulation of lipolysis is warranted. With tissue-
specific differences in metabolic demands, perhaps the relationship between ATGL, CGI-
58 and G0S2 can be indicative of known lipolytic profiles across a variety of lipolytic 
tissues.  
However, G0S2 does appear to play an alternate role within mitochondria (9, 22). 
In cultured ATP depleted hypoxic cardiomyocytes, G0S2 interacts with Complex V 
(FoF1-ATP synthase) positively regulating ATP production (9). Interestingly, in human 
primary fibroblasts placed under TNF-α stress, G0S2 binds to Bcl-2, preventing the Bcl-
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2/Bax anti-apoptotic heterodimer, thereby promoting apoptosis (22). While the functions 
appear to vary, it is interesting to note specific functions of G0S2 within mitochondria as 
a cell modulator in not only energy production, but also cell viability. 
Most studies to date have focused on G0S2 mRNA expression, and few studies 
have reported G0S2 protein content.  Even fewer studies have examined G0S2 in skeletal 
muscle, so there is little understanding of the basal protein content across varying 
oxidative muscle tissues (13, 17). 
The purpose of this study was twofold: 1) to determine ATGL, CGI-58 and G0S2 
mRNA expression and protein content in three metabolically different rat skeletal 
muscles (i.e., soleus, red gastrocnemius and white gastrocnemius), as well as in heart; and 
2) to determine the G0S2-to-ATGL and CGI-58-to-ATGL ratios within the skeletal 
muscle tissues to gain information on whether the relative content in these tissues would 
correspond to the relative reliance on lipolysis for energy production.  
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METHODS 
Animals 
Male Sprague-Dawley (n = 9; age 56 days, body mass 272 ± 2 g), were used for this 
study. Rats were ordered from Charles River Laboratories (Quebec, Canada). Animals 
were housed for 48 hours after delivery in paired cages in a controlled 12:12 hour light to 
dark cycle in the Brock University Animal Facility. Food was fed ad libitum with access 
to water at all times. All experimental procedures and protocols are approved by the 
Brock University Animal Care and Utilization Committee and conformed to all Canadian 
Council on Animal Care guidelines (Animal Utilization Project Protocol permit number: 
13-03-03)(16). 
G0S2 Knockout mice 
Mixed quadriceps muscle (n = 2) of both wild type (WT) and global G0S2 knockout 
(KO) mice were generously provided by Dr. Jun Liu from the Mayo Clinic in Arizona 
(24) 
Muscle extraction  
Rats were anaesthetized by intraperitoneal injections of sodium pentobarbital (6 mg/100 
g body wt). The soleus (SOL), red gastrocnemius (RG), white gastrocnemius (WG) and 
heart were all removed, immediately snap frozen in liquid nitrogen, and stored at  -80oC 
until analysis. 
Citrate Synthase 
The SOL, RG, WG and heart were assayed for citrate synthase activity, as previously 
described by our lab (11). Briefly, frozen tissue was homogenized in 1 M K2HPO4 buffer 
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at pH = 8.1. In a cuvette, a real time reaction was initiated by adding the substrates 
oxaloacetate, triton, acetyl CoA into either tissue homogenate or a blank. Subsequently 
produced free CoASH reacted with 5,5′-dithiobis-(2-nitrobenzoic acid) for colorimetric 
analysis on a GE Ultrospec 2100 pro spectrophotometer (Baie d’Urfe, Quebec, Canada) 
at 412 nm (21). 
mRNA extraction 
mRNA was extracted using a Trizol method (Invitrogen, Carlsbad, USA). 
Complementary DNA (cDNA) was reverse transcribed from total RNA using a High 
Capacity RNA-to-cDNA Kit (Invitrogen, Carlsbad, USA). After reverse transcription, 
cDNA was kept at -20oC.  
Real Time PCR 
SYBR green fluorescent Master Mix was used in all reactions (Invitrogen, Carlsbad, 
USA) with Acidic Ribosomal Protein 36B4 (36B4) as our endogenous house keeping 
control gene (2). Primers were hand selected for ATGL, CGI-58 and G0S2 (Table 1, 
Integrated DNA Technologies). Real time PCR was carried out using a Step One Plus 
thermal cycler (Applied Biosystems). Differences in gene expression between groups 
were determined using the 2-∆∆CT method (12).  
 
Table 2. Name and sequences of primers 
Primer name Forward sequence Reverse sequence 
ATGL 5’- AGA CTG TCT GAG 
CAG GTG GA – 3’ 
5’ – AGT AGC TGA CGC 
TGG CAT TC – 3’ 
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CGI-58 5’ – TAC CCG TCA AGG 
GTC AGT CA – 3’ 
5’ – CAG CAA GAT CTG 
GTC GCT CA – 3’ 
G0S2 5’ – AGC ATG CCT CTT 
AAG GCT GG – 3’ 
5’ – GGA TTC GGT GGC 
ACC TTG AA – 3’ 
36B4 5’ – ATG TGC AGC TGA 
TAA AGA CTG GA – 3’ 
5’ – TGA TCA GCC CGA 
AGG AGA AG – 3’ 
 
 
Western Blotting 
Sodium dodecyl sulphate polyacrylamide gel electrophoresis was performed on 8% (for 
CGI-58), 10% (for ATGL) or 15% (for G0S2) running gel, all with 4% stacking gel. 
Separation was performed at 120V for 90 minutes and transferred onto either a 0.20µm or 
0.45µm polyvinylidene difluoride membrane (Amersham Biosciences, Piscataway, NJ) 
using a 100V current for 1 hour. Blocking was done in either 2% fat free milk in Tris 
Buffered Saline (TBST) (for CGI-58), 5% fat free milk in TBST (for G0S2), or in 5% 
bovine serum albumin (BSA) in TBST (for ATGL). Anti-ATGL primary antibody (Cell 
Signaling Technology, Beverly, Massachusetts, USA #2439s) were diluted at a 1µl: 
700µl in 5% BSA in TBST. Anti-CGI-58 primary antibody (Novus Biologicals NB110-
41576, Oakville, ON, Canada) was diluted at 1µl: 1000µl in 2% powdered milk in TBST. 
For G0S2 we used two antibodies, Anti-G0S2 at a dilution of 1µl: 2000µl N-Terminus 
(Santa Cruz, California, USA sc-133424) and a dilution of 1µl: 2000µl Internal (Santa 
Cruz, California, USA sc-133423) in 5% powdered milk in TBST. All primary antibody 
incubations were at 4°C overnight. All secondary antibodies were conjugated with 
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horseradish peroxidase and incubated for 1 hour at either a 1µl: 5000µl (ATGL), 1µl: 
10000µl (CGI-58) or 1µl: 20000µl (G0S2) dilution. Exposure was in Immobilon Western 
Chemiluminescent HRP Substrate (Millipore; Billerica, Massachusetts, USA). Image 
analysis was performed using band density via ImageJ software produced by the National 
Institutes of Health (Bethesda, Maryland, USA). 
Statistics 
All comparisons were made using a one-way ANOVA with Student-Newman-Keuls 
post-hoc test using GraphPad Prism version 5 for Windows (GraphPad Software, San 
Diego California USA). All statistics were performed on our three skeletal muscles in 
accordance with our a priori hypotheses, with reference made to heart tissue within the 
text. Significance is reported as p < 0.05 ±SEM.  
RESULTS 
Citrate Synthase.  Citrate synthase activity for the heart was roughly 3-fold greater than 
any of the skeletal muscles. When comparing our SOL, RG and WG samples; our results 
were consistent with what has been measured previously (11), with RG demonstrating the 
highest maximal activity (Table 2) (p=0.01).  
 
Table 3.  Maximal citrate synthase (CS) activity in µmol.min-1.g-1 wet wt.   
 SOL RG WG 
CS activity 22.3±2.3a 34.9±1.9b 14.7±1.8a 
Results are mean±SE (n=8). SOL, soleus; RG, red gastrocnemius; WG, white 
gastrocnemius.  Means designated with the same letter are not significantly different 
(p<0.05). 
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ATGL, CGI-58 and G0S2 mRNA.  Real-time PCR analysis quantified mRNA from SOL, 
RG, and WG muscles. ATGL, CGI-58 and G0S2 mRNA content was not significantly 
different across our skeletal muscles (Figure 1). When assessing heart tissue mRNA, 
ATGL and CGI-58 mRNA was almost 2-fold greater than the WG (data not shown).  
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Figure 1.  ATGL, CGI-58 and G0S2 mRNA contents in the three skeletal muscles (SOL, 
RG, and WG, n=9).  Data were calculated according to the delta delta CT method 
relative to WG as explained in Materials and Methods.  Data are reported as 
mean±SE , and there were no statistically significant differences (p<0.05). SOL, 
soleus; RG, red gastrocnemius; WG, white gastrocnemius. 
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ATGL and CGI-58 protein content.  SOL had approximately 2-fold greater ATGL 
protein content compared to WG (p=0.04) with RG not being significantly different from 
either the SOL or the WG (Figure 2, top panel). The range of co-activator CGI-58 protein 
expression (Figure 2, bottom panel) was markedly different from mRNA expression 
(Figure 1, middle panel).  RG and WG had the highest CGI-58 protein content, with the 
SOL having the least. Heart and SOL had similar CGI-58 content.  
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Figure 2.  ATGL (n=8)and CGI-58 (n=7) protein content in the three skeletal muscles 
(SOL, RG, and WG).  Data are reported as mean±SE and bars with the same letter 
are not significantly different (p<0.05).    Insets:  representative blots:  lane 1, WG 
(white gastrocnemius); lane 2, RG (red gastrocnemius); lane 3, SOL (soleus). 
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G0S2 protein content.  Although G0S2 has a predicted molecular weight of 11 kDa, we 
observed two bands that appeared to be G0S2 at 15 kDa and a very strong band at 25 
kDa. To determine if both the 15 kDa and 25 kDa bands were G0S2 protein we used two 
antibodies raised against different regions of the protein (Santa Cruz, California, USA, 
sc-133423, sc-133424), the N-terminus and an internal region, respectively. Both 
antibodies detected the 25kDa and the 15kDa protein band, but when specific blocking 
peptides were pre-incubated with the antibodies (N-13: sc-133424 P, Santa Cruz, 
California, USA. Internal: sc-133423 P, Santa Cruz, California, USA) both bands 
disappeared or were significantly reduced (Figure 3). Both the 25kD and the 15kDa band 
was noticeable in both rat and mouse, with the blocking peptide eliminating both bands in 
both species, suggesting that the antibodies are specific to both bands.  
 
Figure 3.  Establishing that G0S2 protein migrated at both 15 kDa and 25 kDa.  As 
described in Methods, blots were detected with both antibodies (Santa Cruz, sc-
133423, sc-133424) but for the ‘Blocked’ panel, but specific blotting peptides were 
used (Santa Cruz, sc-133423 P. sc-133424 P).  Images were captured at the same 
time to eliminate bias placed upon exposure times and image editing. Three lanes on 
the left were mouse SOL, three lanes on the right were rat SOL. Notice both the 
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25kDa and the 15kDa band show in both species, and both bands disappear with the 
antibody pre-incubation with specific blocking peptides. 
 
To confirm which of the bands was G0S2 we acquired mixed quadriceps skeletal 
muscle of both wild type (WT) and a global G0S2 knockout (KO) mouse (n = 2), a kind 
gift from Dr. Jun Liu (Department of Pediatrics and the Kentucky Pediatric Research 
Institute; University of Kentucky; Lexington, KY USA) (24). Following Western blot 
analyses, the 25kDa band was present in both WT and KO tissues, but the 15kDa was 
only present in the WT (Figure 4). This confirmed that although the stronger 25 kDa 
protein was detected by both antibodies, it was not the G0S2 protein.  In order to detect 
the 15kDa band in all tissues, the membrane was cut to eliminate the stronger band at 25 
kDa so that the weaker 15 kDa band could be detected.   
 
Figure 4.  Comparing a wild type to global G0S2 knockout mouse for the G0S2 protein 
in mixed hind-limb muscle. Notice that in both the WT (wild type) and the KO 
(knockout) lanes that the 25kDa band is present, yet the 15kDa band is only present 
in the WT. The top panel represents the 25kDa band, with the bottom panel 
representing the 15kDa band. 
 
15 kDa G0S2 protein content.  The G0S2 protein content in SOL and RG was not 
significantly different, but both had greater than 2-fold G0S2 protein content compared to 
the WG (p=0.001; Figure 5). The heart was roughly 3-fold greater than the SOL and RG 
(data not shown). 
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Figure 5. G0S2 protein content in the three skeletal muscles (SOL, RG, and WG, n=8).  
Data are reported as mean±SE and bars with the same letter are not significantly 
different (p<0.05). Insets:  representative blots:  lane 1, WG (white gastrocnemius); 
lane 2, RG (red gastrocnemius); lane 3, SOL (soleus). 
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between the muscle types (p=0.11; Figure 6, bottom panel). Interestingly, heart tissue 
WG RG SO
L
0
1
2
3 a
a
b
Tissue
G
0S
2 
pr
ot
ei
n,
 fo
ld
 c
ha
ng
e 
to
 W
G
Figure 5
 54 
had 2-fold greater G0S2-to-ATGL ratio compared to all tissues, yet the lowest CGI-58-
to-ATGL (data not shown). 
 
Figure 6.  Calculated G0S2-to-ATGL (n=8) and CGI-58-to-ATGL (n=7) ratios.  
Data are reported as mean±SE and bars with the same letter are not significantly 
different (p<0.05).  Please note that ratios were calculated from raw integrations in 
arbitrary units.  Blots were always run in same rat pairs for all the proteins and 
tissues and every effort to keep exposure times etc., as consistent as possible to keep 
variation between blots to a minimum. SOL, soleus; RG, red gastrocnemius; WG, 
white gastrocnemius.    
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DISCUSSION 
This study is the first to compare the mRNA expression and protein content of the 
primary regulatory lipase (ATGL) with its recently identified inhibitor (G0S2) as well as 
its co-activator (CGI-58) in non-adipose tissue, such as a model of mixed skeletal 
muscles. To further characterize the expression patterns of these proteins, three 
metabolically heterogeneous skeletal muscles were chosen to represent the three basic 
fiber types:  SOL (primarily type I, slow-oxidative fibers, 84% type Ia; 7% type IIa and 
9% type IIb/x), RG (representative of type IIa fibers, 51% type Ia; 35% type IIa and 14% 
type IIb/x) and WG (primarily type IIb/x fibers, 0% type Ia; 0% type IIa and 100% type 
IIb/x) (3). Several novel findings have been brought forward: 1) we have characterized 
ATGL, CGI-58 and G0S2 mRNA and protein content across several metabolically 
different tissues. 2) The ratios of the inhibitor protein (G0S2) and the co-activator protein 
(CGI-58) to ATGL in the three fiber types appear to be such that highly oxidative type I 
SOL had the lowest activator-to-lipase ratio with the WG having the highest. Contrary to 
our hypothesis, inhibitor G0S2 content was not lowest in the oxidative soleus, but was 
different between skeletal muscles, suggesting that G0S2 protein content alone does not 
regulate lipase activity. 
ATGL and CGI-58 content in skeletal muscle.  
ATGL mRNA and protein content followed similar patterns across our array of 
metabolically different skeletal muscles. There was the greatest amount of ATGL protein 
content in SOL, followed by the RG with the least in the WG. This is understandable 
since it has been previously demonstrated the type I fibers have the greatest capacity for 
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ATGL expression and activity in keeping with their reliance on intramuscular lipolysis 
(8) , and soleus has the highest type I fiber content (3). 
The mRNA expression of lipase co-activator CGI-58 was similar across our array 
of skeletal muscles. This, however, did not translate to similar protein content. RG had 
highest CGI-58 protein expression, which corresponds to high oxidative capacity, 
however the WG has the second highest (although not statistically different from the 
RG), suggesting that type II muscles have very high CGI-58 regardless of oxidative 
capacity and reliance on fat as a fuel. In contrast, in 20-week old mice, Badin et al. (1) 
determined that the heart had the greatest CGI-58 protein compared to the SOL followed 
by the mixed gastrocnemius muscle. The reason for the disparate findings is unclear, but 
could be suggestive of the protein content of CGI-58 being variable based upon the age 
and/or species examined. When expressed relative to ATGL across the three skeletal 
muscles, we see that the SOL has the lowest activator CGI-58-to-ATGL ratio, with the 
WG having the highest in spite of the fact that the SOL has the greatest reliance upon 
intramuscular triglyceride lipolysis as previously demonstrated (20). 
ATGL inhibitor G0S2 mRNA expression and protein content. 
 A novel finding of this study is that G0S2 protein content in sedentary rat skeletal 
muscle appears to mirror that of ATGL protein content with the SOL having the greatest 
protein content of both ATGL and G0S2 (although this difference was not statistically 
different from the RG).  This is contrary to our hypothesis, since it was postulated from 
previous work in primarily adipose tissue and cultured cells that the level of the inhibitor 
G0S2 is indicative of lipolytic reliance or potential of the tissue. Yet our data does not 
support this since the SOL (which relies most upon intramuscular triglyceride energy 
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metabolism) has the greatest G0S2 protein content compared to the WG, which is very 
glycolytic in nature. Recently, it has been observed in mouse heart tissue following 
endurance training-induced cardiac hypertrophy, there was no also change in G0S2 
protein content (4).   However, this physiological adaptation did not change heart lipid 
content either, suggesting that the heart remained unchanged in its reliance upon lipid 
content in response to endurance training (4).  However, these investigators saw that 
following aortic banding, inducing a model of pathological hypertrophy, there was an 
increase in intracellular triglycerides and diglyceride storage within the heart. This was 
accompanied by an increase of heart G0S2 protein, potentially indicative of decreased 
rates of lipolysis.  Taken together, this study suggests that in heart tissue G0S2 as an 
important negative controller of lipolysis (4). However, our interest was in skeletal 
muscle rather than heart muscle, which in general relies more heavily on intramuscular 
fuels for energy production. 
 SOL muscle had the highest amount of the inhibitor G0S2 protein followed by 
RG, which was in turn higher than WG. These results suggest that, contrary to our 
hypothesis, muscles with a higher type I fiber content have more inhibitor than muscles 
with a greater type II content, and the oxidative type IIa RG had more potential for 
lipolytic inhibition than the glycolytic type IIb WG. Further, when expressed relative to 
ATGL content, type I fibers (SOL) had the same relative amount of G0S2 than both type 
II muscles (RG and WG). This seemed surprising as SOL relies very heavily on 
intramuscular triglyceride lipolysis and fat oxidation for energy production (7, 18). 
Indeed, previous work has illustrated that during exhaustive swimming the SOL was the 
most reliant on intramuscular triglycerides compared to RG and plantaris, which in turn 
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were higher than WG (20). Given this, it would appear that the fiber type that is most 
dependent on lipolysis has the highest level of potential inhibitory control as well. 
Therefore, it is not clear why SOL, with its high reliance on intramuscular lipolysis, 
contains the highest protein content of the inhibitory G0S2.  However, in pulse-chase 
experiments, Dyck et al. (6) indicated that the SOL muscle appeared to be very well 
regulated in terms of switching to lipolysis in the face of lower exogenous FFA during 
contraction compared to other metabolic fiber types. In addition, in response to endurance 
training, rat SOL muscle increased intramuscular triglyceride synthesis, and reduced 
lipolysis, which could argue for a higher level of control that could be mediated by G0S2 
(5, 6). Alternatively, if G0S2 has a more important role in regulating mitochondrial 
function through either positive regulation of oxidative phosphorylation (9) or through 
pro-apoptotic pathways (22) our data is consistent with this, given that the more oxidative 
SOL and RG had the highest G0S2 content. 
In summary, it would appear that G0S2 is expressed differently in tissues of 
varying oxidative capacity and reliance on intracellular lipolysis.  However, our results 
do not support the notion that protein content of the inhibitor G0S2 relative to ATGL 
content can predict lipolytic potential in skeletal muscle. Therefore, it is clear that 
regulation of lipolysis is not simply mediated by total content of the important proteins, 
but through more complicated intracellular or post-translational mechanisms.  
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ABSTRACT 
 Lipolysis is a series of cascading catalyzed reactions resulting in the complete 
degradation of a triglyceride molecule caused by the release of three fatty acids and a 
glycerol molecule. Adipose triglyceride lipase (ATGL) is believed to be the first and rate-
limiting enzyme in lipolysis. It is co-activated by comparative gene identification-58  
(CGI-58) and inhibited by the G(0)/G(1) switch gene-2 protein (G0S2), inhibition is 
believed to be in a dose-dependent manner. G0S2 has recently been hypothesized to be a 
positive regulator of oxidative phosphorylation within the mitochondria. Following 
endurance training there is a change in intramuscular triglyceride (IMTG) dynamics, in 
which there is increased storage of IMTGs, and a believed increased reliance on IMTG 
fuel during exercise. Male Sprague-Dawley (n=10, starting age 51-53 days) were 
treadmill trained for 8 weeks starting at 18m/min for 30 minutes ending with 25m/min for 
1 hour, all at a 10% incline. Under isoflurane anesthesia, a sciatic nerve stimulation 
inducing lipoytic hindlimb muscle contraction was administered for 30 minutes to one 
leg, leaving the opposing leg as a resting control. The soleus (SOL, mostly type I fiber), 
red gastrocnemius (RG, mix of type I and type IIa fibers) and white gastrocnemius (WG, 
no type I fibers, mostly type IIb with some type IIa fibers) were removed. ATGL protein 
content increased in all three muscles due in the trained condition, with the most 
pronounced increase witnessed in the glycolytic WG. No change was observed in the co-
activator CGI-58 protein content, with increases in inhibiting G0S2 protein only in the 
trained SOL and trained RG muscles, and with no changes due to acute contraction. In 
isolated mitochondria from the RG, G0S2 protein content mirrored whole tissue, only 
increases in the trained group, with no differences following acute stimulation. In 
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summary, ATGL protein increases in all tissues, with the most pronounced change in the 
least oxidative tissue, however G0S2 only increased in the oxidative tissues, with no 
change in the highly glycolytic WG. As well as, no decrease was observed following an 
acute stimulation suggesting that inhibition of ATGL through G0S2 is not through a dose 
dependent mechanism, but through more complicated intracellular mechanisms. 
INTRODUCTION 
Adipose triglyceride lipase (ATGL) is thought to be the first, and rate-limiting 
step in lipolysis. It is responsible for catalyzing the reaction of removing the first fatty 
acid from a triglyceride molecule releasing the fatty acid for varying metabolic fates and 
subsequently producing a diglyceride (42). ATGL activity is modulated by two 
regulatory proteins (22). It is co-activated by association with comparative gene 
identification-58 (CGI-58), upregulating ATGL catalytic activity by over 20-fold (19), 
and putatively inhibited by the G(0)/G(1) switch gene-2 (G0S2) protein.   It appears that 
this inhibition can override the co-activating effects of CGI-58 (22). It is thought that 
ATGL is directly regulated by influence of both of these proteins since the addition or 
absence of either CGI-58 or G0S2 can directly alter the rates of ATGLs hydrolytic 
capability (19, 22, 32). It was originally speculated that ATGL and G0S2 are always 
bound together (22, 40), yet in fasted human adipose tissue, they witnessed an increase in 
ATGL protein content with a decrease in G0S2 protein content suggesting that there is 
not a 1-to-1 stoichiometry between ATGL and G0S2 and further exploration is needed 
(27). In a completely unrelated role, G0S2 has recently been identified within the 
mitochondria as a positive regulator of complex V (F0F1 ATPase) increasing oxidative 
phosphorylation (17).  
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In human vastus lateralis, Froberg et al. (9), measured intramuscular triglyceride 
(IMTG) content before and after exhaustive cross-country skiing for over 4 hours. They 
discovered that IMTG content was significantly decreased following a single bout of 
exercise, identifying IMTGs as an important fuel source during endurance exercise. 
Following endurance training, it is believed that there is an increase in reliance on IMTG 
stores for energy provision to the muscle. However there are variable results since there 
is no standard method for identifying lipolytic rates and different studies yield a variety 
of different results. Following a 12-week endurance training, Hurley et al. (13) noticed 
that not only was the respiratory exchange ratio lower following training, but there was 
also a decrease in plasma glycerol and free fatty acids following an acute bought of 
exercise, suggesting a greater reliance on intramuscular fat stores for energy provision. 
They also noticed a sparing of muscle glycogen, and a greater drop in IMTG 
concentration during acute exercise following training, as well as a greater total stored 
IMTG following training. Taken together, this would corroborate an increased in muscle 
IMTG use after endurance training.  Increases in reliance on IMTGs can be observed as 
quickly as 5 days of endurance training, with substantial changes being observed at  31 
days (30). The utilization of IMTGs during exercise appear to be fiber type specific, and 
in Sprague-Dawley rats following exhaustive swimming there was a reduction of IMTG 
content by 48% in the soleus, which is a predominantly type I fiber tissue, a 29% 
reduction in the red gastrocnemius, which is a predominantly mixed type I and type IIa 
fiber, with no reduction in IMTG content in the white gastrocnemius, which is almost 
entirely type IIb (34).  Therefore, it appears that the oxidative SOL and RG have a higher 
reliance on IMTG during endurance exercise compared to the WG. 
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It has been demonstrated that ATGL protein content in human mixed fiber vastus 
lateralis skeletal muscle increases with endurance training, with no increase in CGI-58 
(2). Recent work has demonstrated that in obese men who underwent an 8-week 
endurance training protocol, a significant increase in ATGL protein was elicited, with no 
increase in CGI-58 or G0S2 protein content (21). However, there have been no studies 
examining the effects of endurance training on G0S2 protein content in healthy skeletal 
muscle.  
To date, no study has examined the effects of endurance training towards a fiber 
type specific change in ATGL, CGI-58 and G0S2 protein content. Therefore, the purpose 
of our study was 2-fold: 1) To determine the effects of endurance training in varying 
skeletal muscles with varying fiber type composition on ATGL, CGI-58 and G0S2 
protein content, and 2) To determine the effects of both endurance training and an acute 
lipolytic contractile stimulation on whole muscle and isolated mitochondrial G0S2 
protein content. 
METHODS 
Animals 
Male Sprague-Dawley rats (n = 10; 51-53 day old starting age) from Charles 
River Laboratories (Quebec, Canada) were used in this study. All animals were housed in 
a reverse 12:12 light-dark cycle in the Brock University Animal Facility. All animals had 
access to ad libitum food and water at all times. All experimental protocols and 
procedures were approved by Brock University Animal care and Utilization Committee 
and conformed to all Canadian Council on Animal Care guidelines (28).
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Training Protocol 
Rats were randomly assigned to either the trained condition, or the control 
condition (n = 10). Trained rats started at 18 m/min for 30 minutes and by week 8 were at 
25 m/min for 1 hour, all training was done at a 10% incline (7, 8).  Rats were caged in 
pairs with all cage mates in the same condition (either trained or sedentary). Food intake 
and body weight measurements were taken once a week. Food intake was measured by 
combined cage food consumption taking the delta between known starting food weights 
and food weight 7 days later. 
Anesthesia 
Rats were anaesthetized by isoflurane inhalant (induced at 5%, monitored 
between 3-5% during surgical procedures).  
DEXA Scanning 
Three days before the euthanasia, fat, lean and bone mass were measured using 
dual energy X-ray absorptiometry (DEXA) (pSabre, Orthometrix). Under isoflurane 
anaeasthesia, rats were placed supine with all limbs stretched onto the DEXA and a 
region of 10cm wide by 4 cm long starting from the proximal heads of the femur up 
towards the thoracic vertebra. All scans were analyzed with a specialized software (Host 
Software version: 3.9.4; Scanner Software version: 1.2.0) and scanned at a speed of 20 
mm/s with a resolution of 0.5 X 0.5 mm. 
Sciatic nerve stimulation 
During isoflurane-induced anesthesia, sciatic nerve stimulation was applied to 
stimulate the left leg while the right leg served as a resting internal control (11, 36). 
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Briefly, a pulse stimuli was applied once every 3 seconds for 15 minutes, followed by a 4 
minute rest with no stimulation applied with another 15 minutes of a pulse stimuli every 
3 seconds.  
Muscle excision 
Immediately after 30min sciatic stimulation, the stimulated leg was the first leg 
for muscle excision followed by the rested leg. The soleus (SOL), the red gastrocnemius 
(RG) and white gastrocnemius (WG) were all removed and immediately snap frozen and 
kept in liquid nitrogen, with the plantaris removed and mounted in cryomatrix and placed 
in liquid nitrogen until stored at  -80oC until analysis. 
Mitochondrial isolation 
There was sufficient RG muscle tissue to extract mitochondria in our samples, 
and because there were increases in whole muscle G0S2 in response to training in RG, 
this was used to explore whether there were mitochondrial changes as well.  
Subsarcolemmal mitochondrial isolation has been previously described and characterized 
for purity in our lab (31) and adapted from previous studies (14, 29, 37). Briefly, fresh 
RG tissue was minced manually on ice. Following mincing, samples were placed in 20X 
(v/w) of first solution (100mM KCl, 40mM Tris HCl, 10mM Tris base, 5mM MgSO4, 
5mM EDTA and 1mM ATP) and further homogenized in glass potters. When 
homogenized, samples were centrifuged at 700g for 10 minutes, with the supernatant 
being collected and spun again at 14,000g to pellet suspended mitochondria. The 
subsarcolemmal mitochondrial pellet was resuspended in our 2nd solution (100mM KCl, 
40mM Tris HCl, 5mM Tris base, 1mM MgSO4, .01mM EDTA, 1% BSA and 0.25mM 
ATP) and our 3rd solution (100mM KCl, 40mM Tris HCl, 5mM Tris base, 1mM MgSO4, 
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.01mM EDTA, and 0.25mM ATP) and spun at 7000g for 10 minutes. Our final 
purification step was conducted using a 60% Percoll ® (P1644, Saint Louis, MO) gradient 
with final re-suspension in a solution comprising of sucrose and mannitol (220mM 
sucrose, 70mM mannitol, 10mM Tris HCl and 0.1mM EDTA). Samples were stored in a 
-80°C freezer until analysis.  
Oil red-O neutral lipid staining 
Plantaris muscles, embedded in cryomatrix, were cut in 10µm slices and mounted 
onto glass microscope slides. This protocol is adapted from Koopman et al. 2001 (18), 
and has been conducted in our lab previously (23-25). Briefly, samples were fixed in 
3.7% formaldehyde solution for 1 hour followed by a 30-minute incubation in a working 
solution of oil red-O (ORO; O0625; Sigma-Aldrich, St. Louis, MO). After washing, 
slides were coated with 10µl of Prolong Gold Anti-fade reagent (Invitrogen, Carlsbad, 
CA, USA). Images were captured on a Nikon Eclipse 80i fluorescence microscope 
(Nikon Eclipse 80i; Chiyoda-ku, Tokyo, Japan) attached to a Retiga 1300 microscope 
(QImaging, Burnaby, BC, Canada) at 550ηm fluorescence. Images were viewed under 
40X magnification, with three muscle sections per tissue and outlined to determine 
fluorescence using NIS-Elements AR3.00 imaging software (Nikon Instruments, 
Melville, NY). Data was expressed as a fraction of total stained measured area.  
Citrate Synthase 
The SOL, RG and WG from the rested (non-stimulated leg) were assayed for 
citrate synthase activity, as previously conducted in our lab (20). Briefly, tissue was 
homogenized in 1 M K2HPO4 buffer (pH = 8.1) and underwent two freeze/thaw cycles. In 
a cuvette; triton, acetyl CoA, oxaloacetate and the tissue homogenate were added, free 
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CoASH produced reacted with 5,5′-dithiobis-2-nitrobenzoic acid. All analyses was 
conducted in at 412 nm in a GE Ultrospec 2100 pro spectrophotometer (Baie d’Urfe, 
Quebec, Canada) (35). 
Western Blotting 
All Western blotting procedures have been previously optimized and described in 
our lab (Chapter 3). Briefly, SDS-PAGE was performed using 8% (for CGI-58), 10% (for 
ATGL) or 15% (for G0S2) running gels. Electrophoresis was performed for 85 minutes at 
120V and transferred onto 0.45µm polyvinylidene difluoride membrane for ATGL and 
CGI-58 (Amersham Biosciences, Piscataway, NJ) or 0.20µm polyvinylidene difluoride 
membrane (Bio-Rad, Hercules, CA, USA) for G0S2. Anti-ATGL primary antibody (Cell 
Signaling Technology, Beverly, Massachusetts, USA cat#2439s) were diluted at a 1µl: 
700µl in 5% BSA in TBST. Anti-CGI-58 primary antibody (Novus Biologicals, Oakville, 
ON, Canada, cat#NB110-41576) was diluted at 1µl: 1000µl in 2% powdered milk in 
TBST. Two antibodies were used for G0S2 incubation, Anti-G0S2 at a dilution of 1µl: 
2000µl N-Terminus (Santa Cruz, California, USA cat#sc-133424) and a dilution of 1µl: 
2000µl Internal (Santa Cruz, California, USA cat#sc-133423) in 5% powdered milk in 
TBST. Band density was determined using ImageJ (National Institutes of Health, 
Bethesda, Maryland, USA). All blots were made relative to Ponceau stain (Sigma, St. 
Louis, MO, USA) staining as a loading control. 
Statistics 
Body weights, composition, and food weights were analyzed as a two-way 
analysis of variance (2-way ANOVA) for training status x time (week).  SOL and RG 
G0S2 protein content (training status (trained vs. sedentary) x contraction status (rested 
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leg vs. stimulated leg) and were analyzed using a two-way analysis of variance (2-way 
ANOVA) with a Student-Newman-Keuls post-hoc test on Sigma Stat (Systat Software 
Inc., San Jose California, USA). All other statistics were conducted within a given 
muscle (e.g., SOL, RG, WG) using a student’s t-test (trained vs. sedentary) and graphs 
were prepared on GraphPad Prism version 5 for Windows (GraphPad Software, San 
Diego California USA). All graphical representation of Western blot data is made relative 
to the average of the rested sedentary control so that significance does not change when 
compared to arbitrary units. Significance is reported as p < 0.05. 
RESULTS 
Body weights 
Although both sedentary and trained groups increased in size, the sedentary group 
was consistently heavier than the trained group from week 1 to week 7. (p<0.001). 
(Figure 1) 
 73 
 
 
Figure 1a. Body weights of sedentary compared to trained rats from week 0 to final body 
weights one week before final surgeries (n=9). Weights were recorded once a week 
on the same day for all animals on a pan balance. Data are reported as mean±SE,   *, 
signifies significant differences between trained and sedentary for each individual 
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week. There were significant differences for every week compared to each other 
both in sedentary and trained (p<0.05). Sedentary are expressed as the closed circles, 
trained are expressed as the open squares. B. Photo of a representative rat from both 
the trained (left) and sedentary (right) group closest to the mean body weights at 
week 5. 
 
Food Weights 
The trained group ate significantly less than the sedentary group throughout the 
duration of study starting at the first week (p<0.001; Figure 2). 
 
Figure 2 Food weights of sedentary compared to trained rats from the end of week 1 until 
the end of week 6. Food weights are a measure of the difference from starting food 
weight compared to end food weight per cage, then divided by two (n=9). Data are 
reported as mean±SE.   *, signifies significant differences between trained and 
sedentary for each individual week (p<0.05). Sedentary are expressed as the closed 
circles, trained are expressed as the open squares. 
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Body composition (DEXA) 
Lean mass, fat mass and bone mineral content (BMC) were added together to 
create a relative region of interest (ROI). Lean mass, fat mass and BMC were made 
relative to ROI as a percentage of total area measured. There was a 1.3-fold increase in 
lean mass in the trained group compared to sedentary group (p<0.001, Figure 3 – top 
panel). There was a greater than 4-fold decrease in fat mass in the trained group 
compared to the sedentary group (p<0.001, Figure 3 – middle panel). BMC was not 
significantly different between groups (Figure 3 – bottom panel). Bone mineral density 
(g/cm2) was roughly 10% greater in the trained group compared to sedentary (p=0.03, 
Figure 4).  
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Figure 3 Lean mass, fat mass and bone mineral content (BMC) were measured via 
DEXA (n=9). Scans were done by located proximal heads of the femur and 
expanding caudally until scan window was full, analysis was conducted on our 
collected region of interest (ROI) which comprised of our lean mass + fat mass + 
BMC. Data are reported as mean±SE.  *, signifies significant differences between 
trained and sedentary (p<0.05). The sedentary rested group is expressed as the open 
bars, with the trained rest group the closed black bars. 
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Figure 4 Bone mineral density (BMD) was collected using DEXA (n=9). BMD is an 
absolute measure in g/cm2. Data are reported as mean±SE.  *, signifies significant 
differences between trained and sedentary (p<0.05). The sedentary rested group is 
expressed as the open bar, with the trained rest group the closed black bar. 
 
Citrate Synthase 
As expected, prior to training, SOL and RG had similar CS activity, which was higher 
than WG.  As a result of endurance training, CS activity increased in all three muscles 
such that SOL>RG>WG (Table 1). 
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Table 4.  Maximal citrate synthase (CS) activity in µmol.min-1.g-1 wet wt.   
CS Activity Sol RG WG 
Sedentary 32.5±1.8a 29.4±4.5a 15.3±3.1b 
Trained 54.8±4.1c 42.1±3.9d 27.9±3.1f 
Results are mean ±SE (n=10). SOL, soleus, RG, red gastrocnemius, WG, white 
gastrocnemius (n=9). Means assigned with the same letter are not significantly 
different (p<0.05). 
 
ATGL protein content 
There was a 1.3-fold increase of ATGL protein content in the trained SOL muscle 
compared to the sedentary group (p=0.02, Figure 5 – top panel), a 1.7-fold increase of 
ATGL protein content in trained RG compared to the sedentary group (p=0.04, Figure 5 – 
middle panel) and almost a 2-fold increase in ATGL protein content in trained WG 
compared to the sedentary group (p=0.04, Figure 5 – bottom panel). 
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Figure 5. ATGL protein content from our three rested skeletal muscles (SOL, RG, WG, 
n=9). Data are reported as mean±SE.  *, signifies significant differences between 
trained and sedentary (p<0.05). The sedentary rested group is expressed as the open 
bars, with the trained rest group the closed black bars. 
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CGI-58 protein content 
There were no significant differences in CGI-58 protein content due to endurance 
training compared to the sedentary group in SOL (p=0.7, Figure 6 – top panel), RG 
(p=0.7, Figure 6 – middle panel) or WG (p=0.8, Figure 6 – bottom panel).  
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Figure 6 CGI-58 protein content from our three rested skeletal muscles (SOL, RG, WG, 
n=9). Data are reported as mean±SE.  *, signifies significant differences between 
trained and sedentary (p<0.05). The sedentary rested group is expressed as the open 
bars, with the trained rest group the closed black bars. 
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Whole muscle G0S2 protein content 
There were increases in G0S2 protein content in response to training in the SOL 
and RG, protein content was assess both for training status (trained vs. sedentary) and 
sciatic stimulation (rest vs. stimulated leg). A 2-way ANOVA was performed on both 
SOL and RG with no interaction observed. A main effect was observed for training status 
with the trained group having a greater G0S2 protein content compared to the sedentary 
group in both the SOL p<0.001, Figure 7 – upper panel) and RG (p=0.005, Figure 7 – 
middle panel) with no main effect discovered for sciatic stimulation. There was no 
difference in G0S2 protein content in the WG in either the trained group or sedentary 
group (p=0.9, Figure 7 – bottom panel).  
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a. 
 
b.  
 
Figure 7 a. G0S2 protein content from both rested and stimulated legs of SOL and RG in 
both trained and sedentary groups as well as G0S2 protein content of rested WG 
(n=9). Data are reported as mean±SE.  ‘*’ signifies significant differences (p<0.05). 
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The sedentary rested groups are expressed as the open bars, the sedentary stimulated 
groups are the light grey bars, with the trained rest group the closed black bars and 
the trained stimulated group are the dark grey bars. b. G0S2 protein content in the 
WG between sedentary and trained. Data are reported as mean±SE. 
 
Mitochondrial G0S2 protein content 
Because there were increases in whole muscle G0S2 in RG and there was 
sufficient tissue to extract mitochondria, we examined whether there was any change in 
mitochondrial enrichment of G0S2 following training, and whether this was altered by an 
acute bout of muscle contraction.  There was a main effect for training status such that 
there was a 2-fold increase in G0S2 relative protein content in mitochondria from trained 
RG muscle (p=0.01, Figure 8) compared to mitochondria from sedentary RG muscle, but 
there were no differences observed with contraction in either group (p=0.6).  	  
  
Figure 8. Mitochondrial G0S2 protein content from both rested and stimulated legs of 
isolated RG mitochondria in both trained and sedentary groups (n=9). Data are 
reported as mean±SE.  *,  signifies significant differences between trained and 
sedentary (p<0.05). The sedentary rested group is expressed as the open bar, the 
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sedentary stimulated group is the light grey bar, with the trained rest group the 
closed black bar and the trained stimulated group is the dark grey bar.  
 
Muscle lipid content 
No interaction was observed, however main effects for both training status and 
sciatic stimulation was observed. Following stimulation there was a decrease in 
intramuscular lipid content (p<0.001) regardless of training status. However, trained rats 
had a higher level of intramuscular lipid content compared to sedentary rats, regardless of 
sciatic stimulation (p=0.004, Figure 9). 
 
 
Figure 9.  Muscle lipid content from trained and sedentary groups both with and without 
sciatic stimulation from the plantaris muscle (n=9). Data are reported as mean±SE 
with an ‘*’ signifying significant differences between trained and sedentary 
Se
de
nta
ry
Tr
ain
ed
0.0
0.2
0.4
0.6
0.8
_________
_________
______________
__
__
__
__
_
*
In
tr
am
us
cu
la
r 
lip
id
 c
on
te
nt
(a
re
a 
fr
ac
tio
n 
st
ai
ne
d)
 86 
(p<0.05). The sedentary rested group is expressed as the open bar, the sedentary 
stimulated group is the light grey bar, with the trained rest group the closed black 
bar and the trained stimulated group is the dark grey bar. 
 
Discussion 
This study is the first to examine the effects of endurance training in several 
metabolically different skeletal muscles (soleus, red and white gastrocnemius) on the 
relative protein expression of adipose triglyceride lipase (ATGL), it’s co-activator, 
comparative gene identification – 58 (CGI-58) and it’s inhibitor the G(0)/G(1) switch 
gene-2 protein (G0S2). Using a multi-muscle model allowed us to examine any potential 
differences in fiber type as the SOL is primarily a type I (slow oxidative) fiber tissue 
(84% type Ia; 7% type IIa and 9% type IIb/x), the RG being representative of mostly a 
mix of type I and type IIa fibers (51% type Ia; 35% type IIa and 14% type IIb/x) and the 
WG being almost entirely type IIb (0% type Ia; 0% type IIa and 100% type IIb/x) (5). 
Our oil red-O muscle lipid data supports our sciatic stimulation muscle contraction 
protocol as a model for inducing muscle lipolysis, although this was unable to show any 
differences between our trained group and sedentary, perhaps due to the insensitivity of 
oil red-O staining or perhaps to the contraction stimulus. In voluntary contraction, type I 
fibers are recruited first during lower maximal voluntary contraction, and as the 
contraction force increases, type IIa followed by type IIb fibers get recruited (12). With 
forced electrical stimulation, such as a sciatic stimulation, this does not appear to be the 
case. It is thought that motor unit recruitment no longer follows a sequential fiber type 
contraction, but a more random or perhaps even reverse pattern occurs such that type IIb 
fibers are contracted at the same rate, or perhaps recruited earlier than type I (10). This 
fixed fiber contraction rate appears to lead to differences in metabolic rate and perhaps 
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substrate reliance, and significantly decreases time to fatigue with stimulated contraction 
(reviewed by (26)). Therefore, the sciatic stimulated contraction may not yield 
demonstrated increases in IMTG reliance due to endurance training since stimulated 
motor unit recruitment is not consistent with voluntary muscle contraction. Our training 
protocol did however appear to yield conformational changes despite no apparent 
changes in IMTG reliance since there was significantly greater lean mass in our trained 
group compared to the sedentary, with fat mass being the greatest in the sedentary group. 
When comparing body weights, the sedentary group weighed significantly more every 
week compared to the trained group after the first week. This is interesting since it 
appears that the sedentary group ate significantly more compared to the trained group, 
despite the expected greater energy expenditure in the trained group, therefore a greater 
need for food consumption. One possible explanation for this is that it has been observed 
that the predominate feeding time for rats is during the light cycle (4), while our rats were 
trained during the dark cycle, it can be speculated that perhaps the trained rats required 
more sleep and prioritized this before eating. Following an acute bout of exercise, it was 
noticed in human adult males that there was a brief appetite suppression delaying the 
onset of feeding post exercise, with chronic exercise leading to a negative energy balance 
such that this appetite suppression led to a significant decrease in energy consumption 
compared to energy expenditure (16). 
Several novel findings have been identified: 1) ATGL protein increase in all three 
skeletal muscles, yet the largest increase is in WG that historically relies the least on fat 
as a fuel source; 2) CGI-58 protein content does not change regardless of skeletal muscle 
and training status; 3) G0S2 protein increases following endurance training, but only in 
 88 
the SOL and RG, with no change observed in the WG; and 4) RG subsarcolemmal 
mitochondrial G0S2 protein is increased in the trained group compared to the sedentary, 
however, there were no observable effects stemming from the lipolytic inducing sciatic 
stimulation. 
ATGL protein content 
ATGL protein content was increased in the trained group compared to the 
sedentary group. This has been reported before (2, 3, 21, 41); however, ATGL protein 
increased across a variety of skeletal muscle tissues, with the largest increase in the 
glycolytic WG. Jocken et al. (15) immunostained in human vastus lateralis for ATGL 
protein and determined that ATGL is only expressed in type I fibers. We have previously 
demonstrated that ATGL has the greatest expression in SOL, which is predominantly 
type I fibers, but to a lesser degree ATGL is also expressed in the WG, which has no type 
I fibers (Chapter 4). The differences in results however, can be accounted to 
methodological differences since immunohistochemical analysis relies much more on 
threshold detections compared to western blotting. Therefore, it is understandable that 
there are increases in ATGL protein content due to endurance training, since there is a 
fiber type shift in oxidative fiber types with a decrease in type IIb  (as reviewed by (33)). 
CGI-58 protein content  
CGI-58 protein content was unchanged regardless of training status; this was 
consistent across all of our skeletal muscles. It has been previously demonstrated in 
several studies that CGI-58 does not change, regardless of training status. Most studies to 
date have focused on human vastus lateralis, and thus we have added to this information 
by demonstrating that, regardless of the skeletal muscle preference towards oxidative or 
 89 
glycolytic metabolism, CGI-58 protein content is unaltered. This is interesting, since 
previously we have demonstrated that relative CGI-58 protein content is different across 
the SOL, RG and WG, with the SOL having the least relative amount of CGI-58 
compared to the RG and WG (Chapter 4). Perhaps the RG and WG might need to be 
more sensitive to changes in energy provision, so that the tissue can increase lipolytic 
rates in situations with increased prolonged energy demands to the muscle. 
G0S2 protein content  
We are the first to demonstrate that G0S2 protein content increases following 
training in skeletal muscle, but the effects of training appear to be fiber type specific, 
since G0S2 protein content only increased in the SOL and RG, and remain unchanged 
regardless of training status in the WG. Previous work in heart tissue demonstrated that 
following physiological heart hypertrophy caused by endurance training, there was no 
increase in heart G0S2 protein or in cardiac lipid storage (6).  This was in sharp contrast 
to pathological heart hypertrophy caused by aortic banding, where there was an increase 
in triglycerides and diglycerides, as well as an increase in G0S2 protein content (6). This 
is interesting since porcine adipose tissue G0S2 mRNA expression was significantly 
greater during adipogenesis (1), which could explain why not only is there an increase in 
G0S2 protein content due to pathological hypertrophy which increased cardiac 
intracellular lipid content, but also in our current study, which we determined that we had 
a greater intramuscular triglyceride content in resting muscle following endurance 
training. 
Interestingly, it has been postulated that ATGL and G0S2 are always bound 
together (22, 40), therefore an increase in one protein should result in an increase in the 
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other. However, we have demonstrated that if this is true, then it is not likely a one-to-one 
stoichiometric relationship and perhaps that there are pools of either ATGL or G0S2 that 
are separate from each other. Nielsen et al. (27) demonstrated in human adipose tissue 
following fasting that ATGL protein content increased, while G0S2 protein content 
decreased, most likely to facilitate lipolytic rates, since there were greater rates of 
circulatory free fatty acids. This is of particular interest, since not only do they 
demonstrate that ATGL and G0S2 protein content can have inverse expression, but also it 
is postulated that in a heightened state of lipolytic demand, ATGL protein content 
increased to facilitate triglyceride breakdown, and that G0S2 protein decreased to reduce 
its inhibitory control over ATGL. In a G0S2 overexpressing HeLa cells, Lu et al. (22) 
discovered that despite CGI-58 supplementation in an attempt to stimulate lipolysis, 
ATGL was unable to catalyze the conversion of a triglyceride to a diglyceride indicating 
that levels of G0S2 could regulate ATGL activity. Further support for this came from 
research using a G0S2 knockdown HeLa cell line, where both basal and stimulated 
lipolysis was significantly increased (40). Not only does this suggest non-competing 
mechanisms for co-activation/inhibition, but also that G0S2 protein dose dependently can 
inhibit ATGL function. This is contradictory to our findings since we had an increase in 
both ATGL and G0S2 following training in our oxidative tissues, but also that we had no 
change in G0S2 protein content following a 30 min lipolytic muscle contraction, 
suggesting that G0S2 protein content alone does not indicate ATGL function in skeletal 
muscle.  
Louche et al. (21) studied the effects of endurance training in obese males on 
skeletal muscle ATGL and G0S2 protein content. Following training, they observed a 
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robust increase in ATGL protein content, yet no change in G0S2 protein content. These 
results are similar to our WG data, in that in our trained group there was increase in 
ATGL protein content, yet no change in G0S2 protein content. In obese subjects, there is 
significantly less type I fibers with a greater proportion of type IIb fibers (38), which is a 
similar fiber distribution to that of the WG, which is suggestive of a fiber type preference 
for G0S2 protein upregulation due to training.  
Mitochondrial G0S2 content 
A novel finding from this study is that in isolated RG subsarcolemmal 
mitochondria, there was an increase in G0S2 protein content in our trained group 
compared to our sedentary group, however there was no change due to an acute 30 min 
lipolytic contraction, in either the trained or sedentary group. Two separate studies have 
identified G0S2 as a specific mitochondrial protein. Welch et al. (39) determined that 
G0S2 interacts with Bcl-2 promoting apopotosis, and Kioka et al. (17) determined that 
G0S2 interacts with complex V (F0F1 ATPase) positively up regulating ATP production. 
While we can not comment on the apoptotic effects of G0S2, following muscle 
contraction that promoted lipolysis, there were no acute changes in mitochondrial G0S2 
protein content, therefore suggesting that regulation of complex V by G0S2 is through 
more complicated post-translational mechanisms, and not necessarily through 
mitochondrial enrichment of G0S2.  
 In summary, ATGL protein content increases due to endurance training, and the 
relative increase in ATGL is greatest in the WG, which typically relies on fat the least for 
energy production. This however, does not support to co-ordinate expression of G0S2 
protein content, since the WG is the only one the three skeletal muscles studied that did 
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not demonstrate an increase in G0S2 protein content. Within the SOL and RG and 
isolated mitochondria from the RG, there were increases in G0S2 protein content due to 
training; however, there were no acute changes due to a lipolytic inducing contraction. 
This suggests perhaps a chronic regulation of G0S2 protein content. Our study suggests 
that while G0S2 may have inhibitory effects on ATGL, and alternate effects within the 
mitochondria, these specific functions appear to be under more complicated control other 
than protein content alone, perhaps through post-translational or intracellular 
mechanisms.   
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Chapter 6 
Integrative discussion 
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Since the discovery of what is now considered the rate-limiting enzyme of 
lipolysis, adipose triglyceride lipase (ATGL) in 2004 (7, 19, 24), there have been many 
studies contributing to our understanding of the regulation of ATGL in adipose tissue. 
However, significantly fewer studies have focused on ATGL regulation in skeletal 
muscle. In adipose tissue, lipolysis appears to be regulated predominantly by PLIN1, 
which is a protein that surrounds adipose tissue lipid droplets (3), regulating the release 
of CGI-58 to co-activate ATGL activity (4).  PLIN1 is absent or in very low 
concentrations in skeletal muscle, therefore the regulation of ATGL appears to be reliant 
much more on direct protein regulation through co-activation by CGI-58 (11), and 
inhibition by the G(0)/G(1) switch gene-2 protein (G0S2) (13, 22).  
Summary of findings 
 There have been several elegant studies indicating a dose-dependent inhibition of 
ATGL by G0S2 in HeLa cells, suggesting that in situations where lipolysis is increased 
through ATGL catalytic activity, it perhaps is controlled by the relative content of G0S2 
decreasing to release inhibition over ATGL (13, 22). Results from Chapter 4 indicate that 
protein content alone does not relate to resting metabolic behavior, since there is the 
greatest G0S2 protein in the highly oxidative soleus muscle, which happens to 
correspond to greatest levels of ATGL levels. Understanding the importance of the 
relative ratio of G0S2-to-ATGL across these tissues demonstrated that the glycolytic 
white gastrocnemius did not have the greatest G0S2-to-ATGL ratio compared to the more 
oxidative muscles, contradictory to what would be expected if G0S2 inhibition was 
dictated through G0S2 protein content alone.  
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It was initially hypothesized that ATGL was exclusively expressed in type I fibers 
(8), and results from Chapter 4 indicate that ATGL is predominantly expressed in type I 
fibers since there was the greatest amount of ATGL in the soleus with slightly less ATGL 
in the mixed oxidative/glycolytic red gastrocnemius. There was however, detectable 
levels of ATGL in the highly glycolytic white gastrocnemius, which contains essentially 
no type I fibers (5). To speculate on these results, perhaps ATGL protein is exclusively 
expressed in oxidative fibers such that not only type I, but also type IIa fibers, accounting 
for minor relative protein content in the almost exclusively type IIb white gastrocnemius, 
which has been reported to have roughly 8% type IIa fiber composition (5).  
 Throughout the endurance training protocol, there was a significant decrease in 
body weight in the trained group when compared to the sedentary group (Chapter 5). This 
was consistent with the sedentary group eating more food weekly compared to the trained 
group. As the training progressed, body weights from both the trained and sedentary 
groups increased, with the sedentary groups gaining more weight, however there was no 
linear increase in food intake for both groups despite weekly increases in body weights. 
In male and female Osborne Mendel rats, there were time related increases in body 
weights, however only males differed in body weights due to training when compared to 
gender matched sedentary controls, where they had lower weights due to training, with 
female rats having no differences between gender matched groups (1). Interestingly, 
when food weight was compared, there were no differences in cumulative food intake 
during the twelve-hour dark cycle in either males or females regardless of training status, 
however during the twelve-hour light cycle, the only change that was observed was a 
decrease in food consumption with the endurance-trained male rats. This is suggestive of 
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not only a gender difference between males and females for body weights and food 
consumptions, also a time preference for feeding behavior, which is especially interesting 
since the training protocol was conducted during the start of the twelve-hour dark cycle. 
However, this also could be suggestive of the trained group sleeping more while the 
sedentary group perhaps ate. Male Sprague-Dawley rats were treadmill trained for four 
days a week, with the other three days sedentary, during the training period, there was a 
reduction in both food intake and body weight, yet during the sedentary phase, these 
effects were attenuated (18). In lean healthy human males, there was a short term appetite 
suppression following exercise which delayed the onset of feeding post workout, 
however there was only an observed negative energy balance observed during longer 
exercise bouts (9). To speculate, perhaps during the training periods, the redistribution of 
blood flow away from the stomach (2), to the muscle leads to a decrease in appetite.  
Rodent and human training protocols cannot be directly compared since rodent 
training is through the use of four limbs, with human treadmill endurance training being 
bipedal. A strength of rodent skeletal muscle is the homogeneity of the muscle fiber 
types, however this is not consistent with human skeletal muscle, since human skeletal 
muscle is much more mixed. Following a progressive 9-week training protocol on 
stationary bicycles, there was an increase in vastus lateralis citrate synthase from 13.7 to 
23.2 µmol.min-1.g-1 wet wt, this is similar to the changes observed in chapter 5 in the 
white gastrocnemius which went from 15.3 to 27.9 µmol.min-1.g-1 wet wt (6).  
G0S2 as a lipolytic inhibitor 
In G0S2 overexpressed HeLa cells, there was a decrease in lipolytic rates as it 
was observed that G0S2 localized to the lipid droplet membrane, preventing triglyceride 
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degradation through inhibition of ATGL. This was done perhaps through direct 
interaction between the patatin-like domain of ATGL with the hydrophobic region of 
G0S2 (22). Following knockdown of G0S2 in HeLa cells, there was an acceleration of 
both basal, and isoproterenol stimulated lipolysis, identifying G0S2 as a direct inhibitor 
on ATGL regulating the inhibition of lipolysis. In Chapter 5, it was shown that ATGL 
protein content increases due to endurance training. While this result alone is not novel, 
the discovery that there were increases across a range of metabolically diverse skeletal 
muscles, such that the greatest increase observed was in the white gastrocnemius, which 
had the least amount of ATGL protein content when compared to the soleus or the red 
gastrocnemius in resting sedentary muscle is novel. With CGI-58 unchanged, based on 
previous literature indicating that lower total G0S2 content could predict higher rates of 
lipolysis, it was expected that G0S2 protein content would decrease due to endurance 
training. However, contrary to our hypothesis, there were substantial increases in G0S2 
protein content in both the oxidative soleus and red gastrocnemius with endurance 
training, yet there was no change in total G0S2 protein content in the soleus or red 
gastrocnemius following an acute lipolytic inducing contraction, suggesting that G0S2 is 
not a physiological dose dependent inhibitor of ATGL in skeletal muscle since there was 
no decrease in G0S2 protein content following a contraction protocol that significantly 
reduced intramuscular lipid content. In subcutaneous adipose tissue from adult males 
following a 72-hour fast, an increase in ATGL protein content was observed, with a 
decrease in G0S2 content (14). The fasting condition caused an increase in circulating 
free fatty acids indicating a breakdown of lipid droplets from adipose tissue, which is 
putatively facilitated by the decrease in G0S2 protein content. Alternatively, in the same 
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study, an acute bout of exercise conducted in a separate trial from the fasting condition, 
similar amounts of free fatty acid release was observed, with a decrease in c-peptide as 
well, however there were no detectable changes in ATGL or G0S2 protein content. The 
decrease in C-peptide following both protocols is important to note since it is postulated 
that G0S2 protein is modulated by circulating insulin levels (15, 22), however the 
decrease in insulin following an acute bout of training led to no changes in G0S2 protein 
content, yet following fasting there was a decrease in G0S2 protein content, suggesting 
alternative regulation. Although, this perhaps is tissue specific, since it has been 
demonstrated in skeletal muscle that before and after a hyperinsulinemic-euglycemic 
clamp, there was a significant increase in G0S2 mRNA expression (15), yet in 3T3-L1 
mouse adipocytes stimulated with either insulin or isoproterenol, there were no acute 
effects altering the G0S2-to-ATGL interaction, yet following chronic exposure there was 
a decrease in G0S2 with an increase ATGL (22). Our results are consistent with G0S2 
perhaps being a long-term regulator of ATGL, however with contradictory results as 
previously reported, since following training we witnessed an increase in G0S2 protein 
content coordinately with an increase in ATGL protein content. 
The only skeletal muscle where there was no observable change in G0S2 protein 
content in response to endurance training was the highly glycolytic white gastrocnemius.   
This is interesting, because there had been a robust increase of ATGL protein content in 
this muscle, suggesting a tissue specific response to training.  
G0S2 as a mitochondrial protein 
Furthermore, there was also increased enrichment of G0S2 protein in isolated 
subsarcolemmal mitochondria from red gastrocnemius in response to endurance training, 
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although this was not altered following acute lipolytic inducing contraction. 
Subsarcolemmal mitochondria, compared to intramyofibrillar mitochondria, is in closer 
proximity to lipid droplets (17). To further complicate the matter, it has been speculated 
that G0S2 within the mitochondria is a positive up regulator of oxidative phosphorylation 
through interaction with Complex V (F0F1 ATPase) (10). Our data are inconsistent with 
this hypothesis, since it is assumed that there is greater ATP turnover during our 30-
minute contraction stimulus, which did decrease intramuscular lipid content significantly, 
yet there was no change in acute G0S2 protein content. Separately, it is speculated that 
G0S2 may have an entirely separate function in the mitochondria, in that it might prevent 
the anti-apoptotic heterodimer of Bcl-2/Bax in turn promoting apoptosis (20). Results 
from both chapter 4 and 5 cannot directly comment on the function of G0S2 in the 
mitochondria, it is however in support that G0S2 being a mitochondrial protein. From 
Chapter 4, whole muscle G0S2 protein content is the greatest in the oxidative soleus and 
red gastrocnemius, both of which have greater mitochondrial densities compared the 
more glycolytic white gastrocnemius (20). Although, if this were entirely true, it would 
be expected that G0S2 would be greater in the red gastrocnemius compared to perhaps 
even the soleus, since it has the greater mitochondrial capability, as represented by citrate 
synthase data in both Chapter 4 and Chapter 5. Further study is required into the 
understanding of the function(s) of G0S2 in both whole tissue and in mitochondria. 
Future studies 
 The results from the research in this thesis suggest that the mechanisms of 
regulation on ATGL are more complicated than previously suggested in cell models, at 
least for G0S2 inhibition on ATGL. This thesis focused entirely on adaptation responses 
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of ATGL, CGI-58 and G0S2 following endurance training (where it is believed that there 
are altered dynamics of intramuscular lipid reliance) and acute lipolytic contraction in 
several metabolically different skeletal muscles, as well as isolated mitochondria, without 
attempting to examine underlying intracellular regulation of the specific proteins. 
Determining the role of G0S2 in lipolysis 
 Through over- and under-expressing G0S2 in HeLa cells, G0S2 has been 
identified as a direct ‘dose-dependent’ inhibitor on ATGL catalytic activity (13, 22). 
However, this thesis shows that G0S2 increases in oxidative tissues, which does not 
support this notion. Future work should explore whether this regulation remains in 
mammalian tissue, and if so, perhaps attempting to explore intracellular or post-
translational modification on G0S2, as well as further exploring the regulation on ATGL. 
Recently, new phosphorylation sites have been identified on ATGL, which may alter 
ATGL translocation ability throughout the cell (21). This is important, since the 
interaction between ATGL and G0S2 may not be determined entirely through G0S2 
modifications alone, perhaps regulation directly on ATGL is required to modify the 
ability of G0S2 to inhibit its catalytic behavior. Before a lipolytic function of G0S2 was 
suggested, it was identified that G0S2 has the potential to be phosphorylated by both 
protein kinase C and casein kinase II (16), although the physiological significance of 
these phosphorylation sites have yet to be ascertained. Moreover, a direct interaction 
through co-immunolocalization or co-immunoprecipitation can be used to determine a 
potential interaction between ATGL and G0S2 in vivo. Previously, it has been theorized 
that ATGL and G0S2 are bound at all times (13), which alone would suggest another 
level of regulation onto the inhibition of ATGL through G0S2. However, this has yet to 
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be determined to be a mammalian interaction, and the physiological significance has yet 
to be determined.  
 Two previous studies to date have examined G0S2 specifically within the 
mitochondria, and have each identified a different, almost opposing, function of G0S2. 
Whether G0S2 is a pro-apoptotic protein (20), or a positive regulator of oxidative 
phosphorylation (10), or regulators of both functions has yet to be further explored. 
However, understanding of G0S2 regulation might supersede this information, since 
specific regulation may in turn facilitate in determine specific functions of G0S2. 
 What may, in future be an exceptional research tool for elucidating specific 
protein function may be in vivo genome editing through a system such as CRISPR-Cas9 
(23). The ability to create a tissue specific knockout animal, without the potential for 
lifelong endogenous adaptations may yet help indicate specific tissue function. Through 
skeletal muscle, or other tissue G0S2 knockout it may aid in determining loss of function 
protein effects. 
CGI-58 function in regulating lipolysis 
 With CGI-58 remaining unchanged following endurance training, but both other 
potential regulators of lipolysis through ATGL change following training needs to be 
further explored. How the co-activation of ATGL occurs through interaction of CGI-58 
remains relatively unexplored, however one potential hypothesis is that CGI-58 is 
perhaps embedded in the membrane of the lipid droplet, and facilitates ATGL exposure 
to its triglyceride substrate (13). CGI-58 appears to have several functions throughout the 
body, since mutations have been identified (up to 8) as reasons for Chanarin-Dorfman 
syndrome (12). Chanarin-Dorfman syndrome is characterized by an increase in 
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triglyceride accumulation, which is consistent with its function as a co-activator of 
ATGL, but patients with Chanarin-Dorfman also suffer from “ichthyosis”, which is 
characterized as rough, scale-like skin, which to date is inconsistent with its role as a co-
activator of ATGL, suggesting at least one other function of CGI-58 within the body. 
Limitations 
 The primary limitation of this thesis is that it is underpowered, as most 
physiological studies are. This is important, since what we report as insignificant results, 
may not have a great enough power to detect any changes. Larger sample sizes could 
benefit future studies by being able to detect smaller changes due to any perturbation on 
lipolytic rates. Using information from Chapter 5, the means, standard deviations and 
samples size (α=0.05), we were under power, β=0.5. However, in order to reach to a 
desired sample size of 22 (if both α=0.05, β=0.8), would not only be financially difficult 
to achieve, but also ethically difficult due to the preventable use of animals. 
   A strength of this study was the model used, since rats are an excellent model to 
study variances in fiber type with having highly homogeneous muscles towards different 
fiber types, with also having mixed muscle. However a limitation is that information was 
gained only from one species, and may not translate into other mammalian physiology. 
As well as, males were only used for this study with many differences in metabolic rates 
between males and females. 
Conclusion 
The purpose of this thesis was to expand our understanding of ATGL, the co-
activator CGI-58, and the inhibitor G0S2 protein. Since it was postulated that the 
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mechanism for inhibition of ATGL through G0S2 was dose dependent, we postulated 
that using a model of three metabolically diverse skeletal muscles, we could profile 
relative expression of ATGL, CGI-58 and G0S2 mRNA and protein content across these 
tissues based on there intramuscular reliance on fat as fuel. Logically, it was discovered 
that ATGL was highest in the oxidative soleus, and lowest in the glycolytic white 
gastrocnemius, yet paradoxically G0S2 protein content followed the same pattern of 
greatest expression in the oxidative soleus, with the least in the glycolytic white 
gastrocnemius. Examining the ratios of G0S2-to-ATGL, there was no difference between 
any of the muscles, suggesting more complicated intracellular mechanisms for inhibition 
in vivo of ATGL by G0S2. Following endurance training, there was an expected increase 
in ATGL protein content across all three skeletal muscles, with the greatest increase in 
the glycolytic white gastrocnemius, with an anticipated no change in CGI-58 protein 
content, however G0S2 protein content increased as well, interestingly however only in 
the oxidative soleus and red gastrocnemius, no change was observed in the white 
gastrocnemius, despite the most robust change in ATGL protein content. Finally, during 
an acute lipolytic inducing contraction, there was no change in whole muscle, or in 
isolated mitochondrial G0S2 protein content, further implying greater regulation of 
protein function since during contraction there was no decrease in G0S2 protein which 
was hypothesized to facilitate lipolysis through the relief of inhibition of ATGL.  
Summary 
The regulation of ATGL via co-activation and inhibition by CGI-58 and G0S2, 
respectively, is still not relatively well understood. Currently, it does appear that CGI-58-
to-ATGL interaction is crucial for the up regulation of ATGL, and that it appears that 
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CGI-58 is saturated in skeletal muscle since no change occurs following endurance 
training, however this may well be explained in the future by further understanding the 
nature of the interaction between ATGL and CGI-58. The inhibition of ATGL through 
G0S2 has yet to be observed in physiological tissues, however several interesting cell 
models have indicated G0S2 as a dose dependent inhibitor of ATGL through increases of 
G0S2 decrease ATGL activity. However, our results do not agree with this hypothesis, 
since not only were there greater proportionate amounts of G0S2 to ATGL in the more 
oxidative skeletal muscles, but there was also an increase in G0S2 protein content in 
these oxidative tissues due to training. Although unknown, perhaps the increase in G0S2 
protein content due to endurance training in skeletal muscle is perhaps a tissue specific 
mechanism for increasing control of lipolytic rates. The results from these studies have 
begun a foundation of examining this triad of proteins in physiological systems to better 
understand the regulation of lipolysis, and perhaps elucidating the true function of the 
G0S2 protein not only in whole tissue, but mitochondrial specific functions as well. 
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